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ABSTRACT 
 
Characterization of RPGR Variants and Their Role in Inherited Retinal Degeneration. 
(August 2011) 
Rachel Nicole Wright, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Michael F. Criscitiello 
 
Retinitis Pigmentosa (RP) refers to a group of inherited retinal dystrophies resulting 
from progressive photoreceptor degeneration and accumulation of intra-retinal pigment-
like deposits.  X-linked forms of RP are frequently caused by mutations in the retinitis 
pigmentosa GTPase regulator (RPGR) gene.  The RPGR transcript undergoes complex 
alternative splicing to express both constitutive (RPGR
ex1-19
) and RPGR
ORF15
 variants.  
Although RPGR is thought to play a role in ciliary function, little is known about the 
physiological significance of expressing two distinct groups of variants.  This study 
compares Rpgr
ex1-19
 and Rpgr
ORF15
 expression in developing photoreceptors using 
immunoblot analysis and immunohistochemistry, assesses ciliary affinity in adult 
photoreceptors by protein fractionation, examines Rpgr function in transgenic mouse 
models and identifies a novel Rpgr
ORF15
 binding partner using a yeast two-hybrid screen.  
 
Our data reveal that Rpgr expression undergoes dynamic temporal regulation during 
retinal development and indicates variability in ciliary localization of Rpgr variants in 
adult photoreceptors.  Utilization of distinct Rpgr variants during stages of photoreceptor 
 iv 
development suggests independent roles.  Further examination of Rpgr function using 
transgenic mouse models over-expressing either the Rpgr
ex1-19 
or Rpgr
ORF15
 variant 
reveals that despite normal ciliary localization, an excess of RPGR
ex1-19 
results in 
atypical accumulation of Rpgr in photoreceptor outer segments, abnormal photoreceptor 
morphology and severe retinal degeneration.  The data indicate that the constitutive 
variant cannot substitute for Rpgr function in photoreceptors and suggest that proper 
maintenance of the Rpgr isoform ratio is critical to photoreceptor viability. 
 
Using mouse retinal cDNA in a yeast two-hybrid screen with the C-terminus of the 
Rpgr
ORF15
 variant, we identified a novel variant of whirlin as an interacting partner.  
Mutations in whirlin result in Usher syndrome, a disorder characterized by hearing loss 
and RP.  RT-PCR and immunoblot analysis were used to confirm the presence of 
selected candidate partners in the retina and interaction was confirmed by pull-down 
assays and co-immunoprecipitation from retinal homogenate.  Immunohistochemistry 
showed co-localization of RPGR and whirlin within photoreceptors and identified 
isoform specific localization of whirlin.  These findings indicate that whirlin binds 
Rpgr
ORF15
 and that this novel isoform may be required for photoreceptor function, thus 
providing a potential mechanism for the RP phenotype observed in Usher syndrome. 
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DFNB31  Deafness, autosomal recessive 31 
IS Inner segment 
LCA Leber‟s congenital amaurosis 
MBP Maltose binding protein 
OS Outer segment 
RCC1 Regulator of chromatin condensation 
RP Retinitis pigmentosa 
RPGR Retinitis pigmentosa GTPase regulator 
RPGRIP Retinitis pigmentosa GTPase regulator-interacting protein 
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CHAPTER I 
 
INTRODUCTION AND LITERATURE REVIEW 
 
“The eyes are the window of the soul.” – English Proverb 
 
Vision is arguably our most fundamental sensory system.  Associations have historically 
been made between blindness and enlightenment, and the loss of vision has long been 
viewed as a tragedy.  Used as a metaphor in classic Greek tragedies and old English 
proverbs, the gift of sight has long been described based upon the practical experience of 
humanity.   
 
Vision and ocular anatomy 
When looking into someone‟s eyes, we easily see several features.  The most 
predominate of these are the pupil, which is the aperture that allows light to enter the 
eye, and the surrounding iris.  While the iris is more commonly known as the pigmented 
feature that gives us our eye color, from a functional standpoint, it is a circular muscle  
that controls the size of the pupil so that more or less light is allowed to enter the eye.   
 
 
 
 
 
 
____________ 
This dissertation follows the style of Journal of Biological Chemistry. 
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The pupil and iris are both covered by a clear, external lens called the cornea, which is 
the most powerful lens in the eye and forms a continuous encasing with the external 
covering of the eye, known as the sclera or “white of the eye” (1) . 
 
What we do not see hidden beneath this exterior are the transparent lens located behind 
the iris and the chambers of fluid between the cornea and iris, between the iris and lens 
and between lens and retina.  The first two chambers, known as the anterior chamber and 
posterior chamber, respectively, are filled with aqueous humour, while the third vitreous 
chamber is filled with a more viscous fluid known as the vitreous humour. 
Although all parts of the eye are important for image acquisition, the retina is the most 
essential, functional part of the anatomy (1).  Since Santiago Ramón y Cajal‟s anatomic 
description of the cell types that constitute the vertebrate retina (2,3), it has been the goal 
of many visual scientists to understand the functional organization of this specialized 
neural tissue.  Modern technological advances, including the advent of electron 
microscopy, microelectrode recording techniques, and immunohistochemistry, have 
recently allowed for rapid advancement in our understanding of the neural circuits 
employed by each functional component. 
 
Introduction to retinal biology 
The retina, which is part of the central nervous system, forms from out pouching from 
two sides of the neural tube during embryonic development.  Known as the primordial 
optic vesicles, these out pouches fold back on themselves to form the optic cup with the 
  
3 
 
inner most layer of the cup, the diencephalic neuroectoderm, developing into the retina 
and the outside epithelial layer remaining a single layer of cells later called the retinal 
pigment epithelium.  Development of the sensory neurons in the retina begins as early as 
the optic vesicle stage with highly coordinated inductive and migratory events.  Cell 
division and subsequent migration of cell nuclei toward the inner surface give rise to the 
various cell types and multi-layered organization of the retina, with development 
proceeding in an inside to outside manner.  Essentially, the retina develops into a piece 
of brain tissue that detects a diverse assortment of stimuli from the outside world.  Its 
highly organized structure, with discrete layers of cells and complex intercellular 
connections, is required for transduction of external stimuli to the cerebral subcortex and 
cortex, which process retinal input to fashion the full range of visual perception that we 
experience (4-6). 
 
When light rays enter the eye, they are focused through the transparent cornea and lens 
on the retina.  In the human eye, the central focal point of the visual axis is called the 
fovea, which is located slightly more nasally than the optic axis (longest sagittal distance 
between the front of the cornea and the furthest posterior part of the eye) and optic nerve 
head.  Although the fovea is unique to the primate retina and some avian species, similar 
specializations of the central retina known as the area centralis and visual streak have 
evolved in other vertebrate species (4,7). 
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Cells in the retina are arranged in highly organized, discrete layers, with the bodies of 
nerve cells arranged in three rows separated by two layers of densely packed synaptic 
connections. The photoreceptors, which make up the first layer, lie at the back of the 
retina, against a dark row of melanin containing cells called the retinal pigment 
epithelium (RPE).  The RPE absorbs stray photons of light, preventing their reflection 
back into the photoreceptors, which would cause blurring of images.  The RPE also 
protects the retina from over exposure to light radiation.  The second layer, called the 
inner nuclear layer, is composed of the horizontal, bipolar and amacrine cell bodies.  
The ganglion cells, which lie near the surface of the retina, make up the third layer.  The 
spaces separating these three layers are also anatomically distinct.  The region containing 
synapses linking the photoreceptors with the bipolar and horizontal cells is known as the 
outer plexiform layer, and the area where the bipolar and amacrine cells connect to the 
ganglion cells is called the inner plexiform layer (4-6). 
 
Photoreceptors are the light sensing neurons in the retina. All vertebrate retinas contain 
at least two types of photoreceptors: rods and cones, which are both anatomically and 
physiologically distinct.  Cones, which are robust, conical shaped structures, mediate 
daylight vision and are critical for visual acuity and color discrimination while rods are 
named for their slender, rod-shaped structure and are generally responsible for low light 
vision (4,8,9).  
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Photoreceptors achieve efficient transduction of light to neural signals in part by the 
elaboration of a specialized organelle for phototransduction known as the outer segment  
(Fig. 1.1).  The outer segment is filled with stacked, membranous disks, which are 
continuously renewed.  Older portions of the outer segment are shed at the tip and new 
membranes are added at the base.  Failure to renew the outer segment leads to 
photoreceptor degeneration (4,10,11).   
 
 
 
Figure 1.1. Schematic diagram of a rod photoreceptor. Rods are anatomically distinct structures composed 
of a biosynthetic inner segment and light sensitive outer segment. All protein biosynthesis takes place in 
the inner segment, and proteins destined for the outer segment are transported via the connecting cilia. 
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The bilipid membranes of these disks contain light-sensitive, visual pigment molecules, 
which consist of the chromophore retinal bound to an opsin protein (rhodopsin in rods 
and conopsin in cones) (12-14).  In the dark, retinal is in the form 11-cis-retinaldehyde, 
the photoreceptors are depolarized, sodium ions flow freely across the cell membranes, 
and the cells release the neurotransmitter glutamine.  Absorption of light photons 
initiates the isomerization of 11-cis-retinaldehyde to all-trans-retinol, which stimulates 
transducin to exchange a GDP for a GTP.  Transducin with GTP then activates 
phosphodiesterase, which subsequently changes cGMP into an inactive GMP.  Since 
cGMP acts as a second messenger and opens calcium ion channels, decreasing [cGMP] 
results in channels closing and the hyperpolarization of the photoreceptor.  Thus, when 
exposed to light, ion channels in the cell membranes close, and the cell goes into a 
hyperpolarized state and does not release neurotransmitter for as long as the light ensues 
(9,15).   
 
The light-sensitive outer segments of photoreceptors are connected to the cells‟ 
biosynthetic inner segment (cell body) via a junctional structure called the connecting 
cilium.  The inner segment contains all of the cell‟s organelles (4).  Photo pigments (i.e. 
rhodopsin and cone opsins) and other outer segment proteins are synthesized in the 
proximal inner segment and are transported via intraflagellar transport (IFT) across the 
ciliary compartment to the distal outer segment.  Passage of proteins through the 
connecting cilium is critical to the function and maintenance of photoreceptors, thus any 
impairment of the IFT results in photoreceptor malfunction (16). 
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Retinitis pigmentosa 
Retinitis pigmentosa (RP), the most common cause of inherited blindness, refers to a 
group of inherited retinal dystrophies that result in progressive retinal degeneration.  
This clinically and genetically heterogeneous group of disorders affects 1 in every 3,000 
to 5,000 individuals (17)
 
and is characterized by photoreceptor cell death and the 
accumulation of intra-retinal pigment-like deposits, from which the disease gets its 
name.  Symptoms include night blindness, progressive loss of peripheral visual fields, 
and eventual loss of central vision (18).  Recent advances in molecular genetics have 
provided new insights into the genes responsible for RP.  To date, more than 30 different 
syndromic forms of RP have been reported (19) and more than 60 non-syndromic 
disease causing loci have been identified (http://www.sph.uth.tmc.edu/Retnet/ provided 
in the public domain by the University of Texas Houston Health Science Center, 
Houston, TX), with documented cases of autosomal dominant, autosomal recessive, X-
linked, and digenic modes of inheritance (20-24).  X-linked forms of RP (XLRP), which 
have a population prevalence of 1 in 25,000, represent one of the most severe classes of 
RP cases, as determined by age of onset and disease progression (20,25-27). 
 
X-linked retinitis pigmentosa type 3 
Of the six XLRP loci identified, mutations in the retinitis pigmentosa GTPase regulator 
(RPGR) gene, which are responsible for X-linked retinitis pigmentosa type 3 (XLRP3) 
(OMIM312610), account for more than 70% of XLRP and approximately 10% of all RP 
cases.  In addition to accounting for more RP cases than any other RP locus identified to 
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date, XLRP3 is considered to be the most severe form of RP with symptoms often 
appearing during the first decade of life (27,28).   
 
Many patients begin to develop difficulties with dark adaptation and night blindness 
during adolescence.  This is often followed by loss of the mid-peripheral visual field and 
gradual loss of the far peripheral visual field.  As the disease progress, they experience 
tunnel vision, which progresses to complete loss of sight with the loss of central vision 
(19). 
 
These visual symptoms are indicative of a gradual loss of photoreceptors.  In most forms 
of typical retinitis pigmentosa, loss of rod function proceeds loss of cone function.  Thus, 
night blindness and loss of peripheral visual field are attributed to the degeneration of 
rods, which mediate dim light vision, and subsequent reduction in cone function is 
associated with progression of the disease and loss of central vision.  There is, however, 
a tremendous amount of allelic variation and clinical variability associated with RP3.  
Mutations in the XLRP3 locus have been associated not only with RP as described 
(25,26,28-30), but also with cone-rod dystrophy (31), cone dystrophy (32) and recessive 
atrophic macular degeneration (33).
 
   
 
In all RP cases, the outer nuclear layer of the retina, which contains the photoreceptor 
nuclei, is severely attenuated due to loss of photoreceptors.  The inner nuclear layer, 
which contains the amacrine, bipolar and horizontal cell nuclei, is at first well preserved, 
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however, many of these cells degenerate as a secondary affect related to the loss of 
photoreceptor function (19). 
 
Identification of the XlRP3 locus and its transcriptional heterogeneity  
Positional cloning of the human XLRP3 locus initially identified a gene between CYBB 
and OTC in Xp21.1 with 19 constitutive exons spanning 60kb of genomic DNA.  The 
locus encodes a ubiquitously expressed protein, hereafter identified as RPGR
ex1-19
, with 
a predicted molecular mass of approximately 90kD.  The first ATG in the transcript that 
is consistent with translation initiation is located 60 bp downstream from the predicted 
transcription start site, and the 815 amino acid open reading frame is followed by a 3‟ 
untranslated region of 280bp terminating in a polyadenylation signal (25,29).  The N-
terminal half of the predicted protein, encoded by exons 2-10, contains 6 tandem repeats 
of 52-54 amino acids, which are highly similar to the conservative RCC1 (regulator of 
chromosome condensation) protein, the nuclear guanine nucleotide exchange factor for 
the small GTPase Ran (25,34,35).  By catalyzing nucleotide exchange for Ran, RCC1 
boasts pivotal roles in regulating nuclear-cytoplasmic transport, mitosis and nuclear-
envelope assembly
 
(36).  Although there is no evidence of a nuclear localization signal, 
as is present in the N-terminus of RCC1, there are two possible GTP phosphate binding 
motifs at residues 13-20 and 30-35 in the predicted RPGR
ex1-19
 peptide.  The C-terminal 
half of RPGR
ex1-19 
contains a domain rich in acidic residues (22% glutamic/aspartic acid 
and 12% lysine/arginine), and ending in a potential isoprenylation anchorage signal.  
The functional CaaX isoprenylation motif, where „a‟ represents an aliphatic residue and 
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„X‟ is leucine, results in proteolytical cleavage of the last three amino acids followed by 
carboxymethylation of the terminal cysteine, thus providing a means of membrane 
anchorage (25,37). 
 
Although linkage data analysis suggests that mutations in XLRP3 are responsible for 
approximately two-thirds of X-linked RP, initial mutational analysis of RPGR found that 
mutations in the RCC1-homologous domain accounted for only 20-30% of patients with 
XlRP3.  Interestingly, no mutations have been found in exons 16-19 (25,27).  
Subsequent mutational screening of XLRP3 revealed that RGPR transcripts undergo 
tissue specific splicing in the retina by skipping of the splicing donor site of exon 15.  
Extension of the constitutive exon 15 into intron 15 results in a retina specific group of 
transcripts that contain exons 1-13 of RPGR
ex1-19 
plus a large, alternatively spliced C-
terminal exon, hereafter referred to as open reading frame 15 (ORF15) (26).  This exon, 
deemed a mutational hotspot, contains an extensive, purine-rich region that harbors a 
high frequency of deletions and insertions, presumably resulting from the repetitive 
nature of this region.  This region, which accounts for the majority of XLRP3 mutations, 
encodes a highly repetitive glutamic acid and glycine rich domain of unknown function 
which is followed by a basic, C-terminal domain (26,28,30). 
 
Functional implications of XLRP3 mutations 
The most clinically severe XLRP3 mutations are found in exons 1-14 of the RPGR locus.  
These consist of all types of mutations including over 30 identified missense and 
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nonsense point mutations (26,28,30,38).  The identification of at least one mutation, 
G436D, outside of the RCC1-homologous domain suggests that unknown putative 
domains between the RCC1-homologous domain and ORF15 maintain a physiological 
role in the retina (28).  Interestingly, four other known mutations within the RCC1-
homologous domain (G173R; 786-787delTG; C469+1G>T, intron 5; c.619+9del, intron 
6), result in an RP phenotype in addition to a ciliary dyskinesia, such as relapsing otitis 
media, recurrent upper respiratory tract infractions and hearing loss.  Although it is 
unclear why this small subset of mutations in the RCC1 homologous domain result in a 
systemic phenotype, this implication nonetheless suggests that RPGR may retain a 
functional role in tissues outside the retina (39-42).  
 
The majority of missense mutations in the RCC1-homologous domain have been shown 
to interfere with RPGR function by altering the functional confirmation of the domain 
thereby reducing or abolishing known protein interactions (43-45).  All of the nonsense 
and frameshift mutations, which include deletions, insertions and duplications, are 
expected to result in early truncation of the protein.  It has been suggested that premature 
stop codons occurring in exons 2-14 may result in low or absent levels of transcript due 
to nonsense-mediated decay (46). 
 
Although ORF15 mutations are generally associated with milder disease states (30), the 
frequency of XLRP3 mutations found in ORF15 make this unusual exon a prominent 
focus for study.  ORF15 mutations consist mostly of small frame-shift insertions and 
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deletions with only a few reports of disease-causing transversions (26,28,30).  
Interestingly, ORF15 can accommodate a variety of in-frame insertions, deletions and 
residue changes without pathogenic consequences (47).  Although it has been 
hypothesized that ORF15 mutations may result in a series of truncated proteins of 
varying length, amino acid sequence and charge (46), this hypothesis has not been 
supported by any experimental data.   
 
Despite phenotypic heterogeneity, there have been some suggested correlations between 
the location of ORF15 mutations and disease penetrance.  Some reports have suggested 
that mutations toward the 3‟ end of ORF15 result in a more mild RP phenotype with 
better retention of rod function  or X-linked cone-rod dystrophy while others have 
suggested that mutations downstream of codon 445 lead to preferential loss of cone 
function with much less effect on rod function (30-32).  There have been numerous 
reports of a variety of genotype-phenotype associations with ORF15 mutations including 
X-linked cone-rod dystrophy, cone dystrophy and atrophic macular degeneration and 
ciliary dyskinesia.  ORF15 mutations have also been associated with X-linked dominant 
forms of RP.  These mutations result in phenotype manifestations in both hemizygous 
males and heterozygous females; however, age of onset is earlier in males (48,49). 
 
Clinical implications 
The high prevalence of XLRP3 mutations in RP patients and the genetic heterogeneity of 
its mutations show that mutational analysis of this locus is of considerable clinical 
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importance.  Although the repetitive nature and high purine content of the ORF15 exon 
make sequencing difficult, satisfactory mutational analysis methods have fortunately 
been described (26).  This technique will be useful in identifying XLRP3 mutations in 
carrier testing and prenatal diagnosis, as well as, for clarifying the mode of inheritance 
(46). 
 
Localization and function of RPGR 
RPGR has been shown to localize to the photoreceptor connecting cilia via interaction of 
its N-terminal RCC1 homology domain to an RPGR-interacting protein, RPGRIP (Fig. 
1.2) (44,50,51).  RPGRIP is a structural component of the ciliary axoneme, and ablation 
of the RPGRIP gene in mice abolishes ciliary localization of RPGR (50,51).  In addition 
to its interaction with RPGRIP, the RCC1 homology domain of RPGR has also been 
shown to interact with at least 4 other known proteins: phosphodiesterase 6D (PDE6D), 
a prenyl binding protein; nucleophosmin (NPM), a shuttling protein; and structural 
maintenance of chromosomes 1A and 3(SMC1/SMC3), two cohesion proteins involved 
in chromosome and mitotic spindle function (43-45,50,52,53).  RPGR is also believed to 
associate with a number of different axonemal or centrosomal proteins involved in 
ciliary transport.   
  
Despite the number of known and potential protein-protein interactions, the function of 
RPGR is not well understood.  The presence of an RCC1 homology domain in RPGR 
and its localization in the connecting cilium suggest that RPGR may regulate 
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intracellular transport in photoreceptors via an unknown G protein.  In mice lacking 
RPGR, cone photoreceptors exhibit ectopic localization of cone opsin in the cell body 
and synapse, and both cone and rod photoreceptors degenerate (51).  This data is 
consistent with the proposal that RPGR plays a role in maintaining polarized protein 
distribution across the connecting cilium by facilitating directional transport or 
restricting redistribution(54).   
 
 
 
 
Figure 1.2. Schematic representation of RPGR variants and their anchorage to the photoreceptor 
connecting cilia. (A) Illustration of RPGR protein variants.  The RCC-1 homology domain, which binds 
RPGRIP and is responsible for ciliary localization, is shown in red.  (B)  Schematic representation of a rod 
photoreceptor illustrating RPGRIP anchorage of RPGR to the connecting cilia.   
 
 
 
Furthermore, while the physiological meaning of the presence of multiple RPGR splice 
variants in photoreceptors is not clear, the conservation of alternative splicing in 
mammalian retina suggests the importance of this splicing process in photoreceptor 
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viability.  Alternative splicing, which is estimated to modify at least half of all primary 
mRNA in mammals, greatly increases the coding complexity of the genome by 
generating a large number of mRNA and protein isoforms from individual genes.  
Molecular analysis has demonstrated that alternative splicing determines the binding 
properties, intracellular localization, enzymatic activity, protein stability and 
posttranslational modifications of a large number of proteins, and is frequently regulated 
in a developmental or tissue-dependant manner.   More than one alternative splice 
isoforms can be concurrently maintained in the steady state mRNA pool of a single 
tissue or cell type, and changes in the isoform ratio have been associated with 
physiological variation and disease susceptibility. 
 
Animal models of XLRP 
An RPGR deficient mouse model confirms ciliary localization of Rpgr in 
photoreceptors, and suggests that ciliary function of Rpgr is facilitative rather than 
central.  In this sense, RPGR may be more appropriately classified as a longevity gene 
required for the long-term maintenance of photoreceptors (54).  Without Rpgr, 
photoreceptors develop normal morphology and are functional and viable for the first 
few months of life.  Although increased staining of Müller cell processes at 2 months of 
age is an early indicator of disease progression, photoreceptor cell loss is not evident 
until 6 months of age with the loss of two rows of nuclei in the outer nuclear layer.  Both 
rod and cone photoreceptors appear susceptible to abnormalities as detected by 
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electroretinography (ERG) and morphology, though only cone photoreceptors exhibit 
ectopic localization of opsins in the cell body and synapses.   
 
This model presents a relatively slow retinal phenotype when compared with the 
observed disease course in human RP3 patients (26,54-57).  Such differences in disease 
progression may be due to different functional consequences between a void in RPGR 
expression versus expression of mutant RPGR.  It has also been suggested that the 
severity of disease progression in RP3 patients may be dependent on additional genes 
affecting RPGR expression and/or function (58).  This may also be the case in the 
RPGR-null mouse model, which may be highly dependent on allelic variation and 
background.  
 
Interestingly, transgenic expression of an ORF15 variant with an in-frame deletion of the 
purine-rich region in the Rpgr null background results in a significant increase in disease 
progression.  Given that co-expression of the wild-type allele does not rescue the 
phenotype, this suggests that the mutant ORF15 variant exhibits a dominant, gain-of-
function activity (59).  A second interesting observation of this model is the retina-
specific differential splicing of the purine-rich region of ORF15 exon in photoreceptors 
versus other cells.  This supports the theory that endogenous Rpgr transcripts undergo 
retina-specific alternative splicing in the purine-rich region (59).  However, subsequent 
rescue of the Rpgr null phenotype by expression of an equivalent, abbreviated ORF15 
variant under the control of a different promoter raises questions regarding the dominant 
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phenotype reported.  This latter report nonetheless suggests that a single Rpgr
ORF15
 
variant is capable of adequately restoring the loss of Rpgr function in the knockout 
mouse model and supports the hypothesis that Rpgr
ORF15
 is a functionally significant 
variant in photoreceptors (60). 
 
An Rpgrip1 deficient mouse model has also been reported (51).  In contrast to the Rpgr 
null model (54), targeted disruption of the Rpgrip1 locus results in an extremely severe 
retinal phenotype with early evidence of outer segment morphological dysplasia and disk 
expansion.  These findings are consistent with mutations in the human RPGRIP1 locus, 
which are attributed to Leber‟s congenital amaurosis (LCA), a severe photoreceptor 
degenerative disorder with appearance of a visual deficit in early childhood (61-63).  
Loss of ciliary localization of Rpgr in the absence of Rpgrip1, suggests that Rpgrip1 is a 
stable component of the connecting cilia where it tethers Rpgr.  Thus, Rpgr is dependent 
on Rpgrip1 for subcellular localization and function.  As a result, a defect in Rpgrip1 
encompasses loss of both Rpgrip and Rpgr function, thus resulting in the more severe 
clinical phenotype associated with LCA (50,54). 
 
In addition to the described Rpgr mouse models, XLRP studies have also centered 
around two naturally-occurring canine mutations.  Reminiscent of the phenotypic 
heterogeneity characteristic of human XLRP3 mutations, mutations in the canine RPGR 
ortholog, which result in X-linked progressive retinal atrophy 1 and 2 (XLPRA1,  
XLPRA2), also exhibit contrasting genotype-phenotype correlations (64).  A 5-base pair 
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(bp) deletion in exon ORF15 of XLPRA1 results in a predicted frame-shift and 
immediate premature stop codon.  While these canines show slow degeneration of rod 
and cone photoreceptors after about 6 months of age, the XLPRA2 canines, which have 
a 2-bp deletion in exon ORF15 resulting in a premature stop codon 71 amino acids 
downstream, exhibit a very severe retinal phenotype with abnormal photoreceptor 
development and rapid degeneration (64).  Differential subcellular localization in 
cultured cells expressing the two allelic variants, shows that while the XLPRA1 ORF15 
peptide exhibits the same cytoplasmic subcellular localization of wild-type protein, cells 
expressing the XLPRA2 mutant allele result in ORF15 colocalization with markers of 
the endoplasmic reticulum.  This data is consistent with observations made in Rpgr
ORF15
 
transgenic mice.  Together, these results suggest that while many RPGR mutations result 
in varying degrees of loss-of-function, a subset of ORF15 mutations exhibit a severe 
gain-of-function phenotype. 
 
Recent identification of two Rpgr orthologs in zebrafish has added zebrafish to the 
available model systems for RPGR studies (65).  Like many zebrafish orthologs of 
human genes, the two homologous RPGR genes reported (zfrpgr1 and zfrpgr2) are 
probably attributed to a genome duplication that occurred in teleosts. Both genes are 
expressed in the developing and adult retina as well as more widely during development.  
Morpholino-induced knockdown of Rpgr expression results in developmental 
abnormalities similar to those associated with knockdown of other ciliary proteins.  
Unlike mammals, RPGR knockdown in zebrafish causes developmental abnormalities 
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including lamination defects, failure to develop photoreceptor outer segments and a 
small eye phenotype.  These defects are rescued by wild-type but not mutant human 
RPGR alleles.  In addition, knockdown of the zfrpgr2 locus also affects retrograde 
intracellular transport of organelles.  Thus, the authors conclude that zfrpgr2 is required 
for normal differentiation and migration of retinal neurons and prevents apoptosis of 
retinal neurons in zebrafish.   
 
Central hypothesis and specific aims 
Based on the published literature, my central hypothesis is that RPGR variants are 
developmentally regulated and functionally distinct, and that maintenance of the 
appropriate isoforms is required to coordinately perform essential tasks and maintain 
normal photoreceptor function.   
 
The experiments presented in the following specific aims are designed to test the above 
hypothesis in the appropriate in vitro and in vivo experimental models. 
 
Aim I:  To analyze RPGR variant expression in the developing retina. 
 
Aim II:  To characterize the functional significance of RPGR variants by 
phenotypic analysis of transgenic mouse models. 
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Aim III:  To further elucidate RPGR function through identification of 
protein-protein interactions. 
 
The knowledge gained by these studies will significantly advance our understanding of 
the functional significance of alternative splicing and the pathogenic consequences of 
RPGR mutations and is a prerequisite for identification of potential therapeutic targets.  
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CHAPTER II 
 
MISEXPRESSION OF THE CONSTITUTIVE RPGR
EX1-19
 VARIANT LEADS TO 
SEVERE PHOTORECEPTOR DEGENERATION 
 
Overview 
Mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene cause of X-linked 
Retinitis Pigmentosa.  The RPGR transcript undergoes complex alternative splicing to 
express both constitutive (Rpgr
ex1-19
) and Rpgr
ORF15
 variants.  Both variants localize to 
photoreceptor connecting cilia and are believed to play roles in ciliary function.  This 
study examined variability in isoform expression and tested whether the constitutive 
variant could substitute for Rpgr function in photoreceptors.  Rpgr
ex1-19
 and Rpgr
ORF15
 
expression during retinal development were compared using immunoblot analysis and 
immunohistochemistry, and ciliary affinity in adult photoreceptors was assessed by 
protein fractionation.  Transgenic mice expressing either the full-length Rpgr
ex1-19
 or 
Rpgr
ORF15
 variant were studied using light and electron microscopy and 
immunofluorescence imaging.  The results were compared with those of wild-type and 
Rpgr
-/-
 mice.  Rpgr expression undergoes dynamic temporal regulation during retinal 
development and variants exhibit variability for ciliary localization in adult 
photoreceptors.  Transgenic expression of both variants grossly exceeded endogenous 
Rpgr expression in photoreceptors.  Although both variants exhibited normal ciliary 
localization, overexpression of the Rpgr
ex1-19
 variant resulted in atypical accumulation of 
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Rpgr in photoreceptor outer segments, abnormal photoreceptor morphology and severe 
retinal degeneration.  The Rpgr isoform ratio in the adult retina is critical to 
photoreceptor integrity.  The utilization of distinct Rpgr variants at different stages of 
photoreceptor maturation suggests independent roles in photoreceptor function.  Finally, 
misexpression of Rpgrex1-19 causes retinal degeneration that is considerably more 
severe than the Rpgr knockout but photoreceptors tolerate overexpression of 
RpgrORF15 without evidence of degeneration.    
 
Introduction 
X-linked retinitis pigmentosa (XLRP) represents the a severe form of retinitis 
pigmentosa (RP), a group of inherited retinal dystrophies that result in photoreceptor cell 
death and the accumulation of intra-retinal pigment-like deposits(25,26).  Symptoms 
include night blindness, progressive loss of peripheral visual fields and eventual loss of 
central vision(18).  Mutations in the retinitis pigmentosa GTPase regulator (RPGR) 
gene account for more than 70% of XLRP and approximately 10% of all RP 
cases(20,25,26). Ablation of the Rpgr gene in mice(54) and naturally occurring 
mutations in dogs(64) also lead to photoreceptor cell degeneration, suggesting that Rpgr 
is essential for mammalian photoreceptor survival.  In addition, both early cone 
photoreceptor defects and rod degeneration indicate that Rpgr is necessary for the 
survival of both rods and cones(30,54,66). 
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Rpgr transcripts undergo a complex splicing process using alternative splicing sites and 
polyadenylation signals to generate constitutive Rpgr
ex1-19
 transcripts and highly variable 
Rpgr
ORF15
 transcripts (Fig. 2.1) (26,37,67,68).  The Rpgr
ex1-19
 variants are widely 
expressed and contain exons 1-13 and 16-19, while numerous Rpgr
ORF15
 variants are 
preferentially expressed in the retina and contain exons 1-13 plus a large, alternatively 
spliced C-terminal exon 14/15 (26,54).  Although both Rpgr
ex1-19
 and Rpgr
ORF15
 localize 
to the connecting cilia through interaction of their constitutive N-terminal domain with 
Rpgrip(44,45,50) and evidence suggests that they regulate protein trafficking through the 
photoreceptor connecting cilia(37,54,69), little is known regarding the physiological 
significance of expressing two distinct variants.   
 
To further investigate the significance of variable variant expression in photoreceptors, 
we compared Rpgr
ex1-19
 and Rpgr
ORF15
 expression during retinal development.  Using 
immunoblot analysis and immunofluorescence microscopy, we observed dynamic 
temporal regulation of Rpgr expression during retinal development.  Although Rpgr
ex1-19
 
is highly expressed in developing photoreceptors, expression is significantly down-
regulated in mature cells.  Emergence of the Rpgr
ORF15
 variant, on the other hand, 
correlates with photoreceptor maturation.  By examining transgenic lines expressing 
only Rpgr
ex1-19
, we also report that an abundance of Rpgr
ex1-19 
expression in mature 
photoreceptors results in abnormal accumulation of protein in the outer segments, 
disruption of outer segment morphology, and rapid retinal degeneration. 
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Figure 2.1.  Schematic representation of the Rpgr gene structure and illustration of Rpgr expression in the 
retina.  Alternative splicing leads to two groups of Rpgr transcripts.  Rpgr
ex1-19
 includes exons 1-13 and 
exons 16-19, while Rpgr
ORF15
 includes exons 1-13 plus a large, alternatively spliced ORF 14/15.  Orange, 
exons encoding RCC1-like domain common to all Rpgr variants; green, remainder of exons common to all 
Rpgr variants; yellow, exons 16-19 encoding Rpgr
ex1-19 
specific C-terminal domain, with isoprenylation 
motif; blue/purple, large exon (ORF 14/15) encoding C-terminal domain of Rpgr
ORF15
; purple, 
alternatively spliced region of ORF14/15 encoding glutamic acid-rich domain.  
 
 
Experimental procedures 
 
Animals 
C57BL/6 wild-type mice were obtained from Harlan Laboratories (Houston, TX).    The 
full length Rpgr
ex1-19
 was cloned from C57BL/6 wild-type retinal cDNA.  Due to 
variable internal splicing of the ORF14/15 exon present in Rpgr
ORF15
 transcripts 
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(37,67,68), a full-length Rpgr
ORF15
 transcript has never, to our knowledge, been 
successfully cloned.  Thus, Rpgr
ORF15
 was cloned from a combination of genomic DNA 
and cDNA.  Exons 1-13 were amplified from retinal cDNA and were joined with a full-
length, unspliced ORF14/15 exon amplified from genomic DNA.  Each clone was 
introduced into a pCBA vector between the cytomegalovirus (CMV) enhancer β-actin 
promoter (CBA), which has been shown to drive expression in both rods and cones, and 
a bovine growth hormone (BGH) polyadenylation sequence.  N-terminal 3x-Myc tags 
were added to distinguish between native and transgenic Rpgr expression.  Transgenic 
mice were generated by pronuclear injection of the described transgenic constructs 
(designated mRDef and mROrf) into C57BL/6 wild-type embryos.  Founder mice were 
bred with C57BL/6 wild-type mice and Rpgr 
-/-
 mice to generate transgenic mice in a 
wild-type and Rpgr null background, respectively.  Rpgr 
-/-
 littermates were used as a 
control for assessment of retinal phenotype.   
 
All animals were maintained on a 12-h light – dark cycle, with food and water ad libitum 
and were handled in accordance with the institutional guidelines as approved by the 
Texas A&M University IACUC (Institutional Animal Care and Use Committee). 
 
Reverse transcription (RT-PCR)  
Total RNA was isolated from retina using Trizol reagent (Invitrogen, Carlsbad, CA), and 
cDNA was generated using the Superscript® One-Step RT-PCR system (Invitrogen, 
Carlsbad, CA) according to the manufacturer‟s instructions.   
  
26 
 
Antibodies 
The polyclonal ORF15 antibody was generated in guinea
 
pig  and has been previously 
characterized(69).  The other Rpgr antibodies were also previously described (50,69).  
The locations of the Rpgr antibodies are shown in the antibody map in Figure 2.2A.  
Green cone opsin antibody (JH492) was provided by Dr. Jeremy Nathans and was used 
as described (70).  Anti-glial fibrillary acidic protein (GFAP) and acetylated α-tubulin 
(T6793) antibodies were obtained from Sigma Aldrich.  
 
Goat anti-rabbit IgG-horseradish peroxidase conjugate and goat anti-mouse IgG-alkaline 
phosphatase conjugate (Pierce) were used as secondary antibodies.  Alexa fluorochrome-
conjugated secondary antibodies for immunostaining were employed (Molecular Probes, 
Inc). 
 
Immunoblot analyses  
Tissues were homogenized in buffer (50mM Tris, pH 7.4, 150mM NaCl, 0.5% NP40) 
containing a protease inhibitor cocktail (Sigma Aldrich) and were centrifuged at 1000 X 
g for 2 minutes.  For denaturing gel electrophoresis, samples were mixed with 4X SDS 
sample buffer with β-mercaptoethanol, separated on polyacrylamide gels and then 
transferred to PVDF membranes (Immobilon-P, Millipore).  After blocking the 
membrane in 5% skim milk in PBS with 0.1% Tween, proteins were detected by 
applying primary antibody overnight followed by the appropriate secondary antibody for 
2 hours.  Immunoreactive bands were quantitatively analyzed using Image J 
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(rsbweb.nih.gov/ij/).  Band densities were measured using simple graphical method that 
involves generating lane profile plots, drawing lines to enclose peaks of interest, and 
then measuring the peak areas (detailed description of method available at 
http://rsb.info.nih.gov/ij/docs/menus/analyze.html#gels).  As a marker, a Precision Plus 
Prestained Standard (Biorad), ranging from 10 – 250kD to 25kDa, was used. 
 
Cellular fractionation 
Four mouse retinas were dissected and kept on ice or 4°C for the remainder of the 
procedure, unless otherwise noted.  The retinas were homogenized in tissue fractionation 
buffer (50mm Tris, pH 7.4; 150mm NaCl, and protease inhibitor). The suspension was 
centrifuged at 500 × g for two minutes to remove large debris. The supernatant was 
centrifuged again at 35,000 × g for 30 minutes. The supernatant was transferred to a 
fresh tube and was designated the cytosolic fraction. The pellet was gently washed in 
fractionation buffer and was resuspended in NP40 buffer (50mM Tris, pH7.4; 150mM 
NaCl; 1% Nonidet P-40).  After incubating 30 minutes at room temperature, the samples 
were centrifuged at 35,000 × g for 30 minutes.  The supernatant was collected and 
designated as the detergent-soluble fraction.  The pellet was carefully washed in NP40 
buffer, resuspended in tissue fractionation buffer and designated the axoneme-enriched 
fraction. 
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Immunohistochemistry  
Unfixed eyes were embedded in optimal cutting temperature (OCT) compound and were 
snap frozen in liquid nitrogen.  Cryosections (10-µm) were cut and collected on 
pretreated glass slides (Superfrost Plus; Fisher Scientific).  Sections were stored at -20°C 
and used within 2 to 3 days.  Immunofluorescence staining was performed as previously 
described(50,54).  
 
Histology 
Eyes were fixed in 4% formaldehyde and were imbedded in optimal cutting temperature 
(OCT) compound.  Histology procedures were carried out as previously described(71). 
 
Dissociated photoreceptors 
Dissociated photoreceptor fragments were obtained by mechanical detachment from 
freshly dissected mouse retinas, as previously described(72).  In brief, retinas were 
suspended in Ringer Solution and were gently homogenized by five passes through a 
disposable transfer pipette.  Cell fragments were allowed to adhere for 5 minutes to 
pretreated glass slides (Superfrost Plus Microscope Slides; Fisher Scientific).  Adhered 
cell fragments were fixed for 5 minutes in ice-cold methanol, before proceeding with 
typical immunocytochemical staining as previously described(50,54). 
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Electron microscopy 
After removal of the lens and vitreous, enucleated eyes were fixed in 2% formaldehyde, 
2% gluteraldehyde in 0.1M cacodylate buffer.  Eyes were washed in 0.1M cacodylate 
buffer for 3 days and were post-fixed in 1% OsO4 for 1 hour at room temperature.  They 
were then washed once in 0.1M cacodylate buffer and once in water and were gradually 
dehydrated in 30%, 50%, 70%, 80%, 90% and 95% cold ethanol for 15 minutes each.  
After warming to room temperature, eyes were incubated in 100% ethanol (15 minutes 
X 3) followed by propylene oxide (PO).  Eyes were infiltrated with 1:2 Epoxy (Epon 
Araldite with 1.5% DMP-30):PO for 1 hour, 1:1 Epoxy:PO for 1 hour, 3:1 Epoxy:PO for 
hour and then with 100% Epoxy.  After transfer to flat molds, they were heat cured at 
65°C for 2 days to polymerize. 
 
Results 
 
Rpgr expression in the developing retina 
Since the retina is the only tissue to co-express both Rpgr
ex1-19
 and Rpgr
ORF15
 variants, 
we examined whether expression of Rpgr variants varied in a temporal manner.  We 
previously showed that Rpgr immunoreactivity is first detectable at the apices of the 
developing photoreceptor layer at day postnatal day 3 (P3), which correlates with the 
timing and location of connecting cilia formation(54).  To further study the dynamics of 
Rpgr expression, we compared the expression of Rpgr
ex1-19
 and Rpgr
ORF15 
at specific 
phases of retinal development.  In the mouse, much of retinal development takes place in 
the three weeks following birth in a process very similar to third-trimester human retinal 
development (73).  Proliferation, migration and differentiation of neuronal precursor 
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cells in the mouse retina is initiated at embryonic day 12 (E12) and continues through 
final neuronal differentiation and maturation at approximately P8(74).  The final stages 
of neuronal differentiation and retinal vascular development occur when mice open their 
eyes and vision is initiated at around P14.  Since many factors critical to establishing this 
visual pathway are regulated during the first two post-natal weeks(75) , we analyzed 
Rpgr protein levels in retinal homogenates from P3, P7, P14 and adult (2-month) wild-
type mice using our anti-S1 antibody (Fig. 2.2A), which recognizes both Rpgr variants.  
Rpgr
ex1-19
 migrates as a 95-100 kDa band on Western blots.  Protein expression was 
detected at times of neuronal differentiation in the retina and decreased with age, with 
robust expression at P3 compared to adult expression levels (Fig. 2.2B).  In contrast, 
Rpgr
ORF15
 migrates at approximately 200 kDa and the emergence of the Rpgr
ORF15
 
variants correlates with the maturation of photoreceptors (Fig. 2.2B, Fig. 2.3B).  
Relative intensities of the Rpgr
ex1-19
 and Rpgr
OFR15
 bands were quantified using ImageJ 
software (Fig. 2.2C).  Thus, our data shows a correlation between changes in the Rpgr 
isoform ratio and photoreceptor development and maturation.  
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To compare the localization of Rpgr
ex1-19
 and Rpgr
ORF15
 variants during retinal 
development, we performed immunohistochemistry on wild-type P3, P7, P14 and adult 
retinas.   Rpgr
ex1-19
 and Rpgr
ORF15
 variants were detected using the anti-S3 and anti-Rpgr 
ORF15 antibodies, respectively (Fig. 2.3A; and antibody map, Fig. 2.2A).  In the P3 
retina, the Rpgr
ex1-19
 was detected as a narrow band at the apex of the developing 
photoreceptor layer (Fig. 2.3A).  The appearance of Rpgr at this time point is consistent 
with the appearance and location of the emerging photoreceptor connecting cilia (Fig. 
2.3B).  The well-defined band persisted through day 14 but severely diminished in the 
adult retina.  Rpgr
ORF15
 was nearly undetectable until P14 and increased in intensity in 
the adult retina (Fig. 2.3A).  This data is consistent with our isoform specific protein 
level analysis shown in Figure 2.2B. 
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Figure 2.2.  Antibody map for mouse Rpgr and comparison of Rpgr
ex1-19
 and Rpgr
ORF15
 expression in the 
developing retina.  (A) Top: Illustration of the Rpgr
ex1-19
 variant structure and the location of domains used 
to generate our RCC1 and S1 polyclonal antibodies, which detect all Rpgr
 
variants, and our S2 and S3, 
default specific polyclonal antibodies.  Bottom: Schematic representation of the Rpgr isoform structure 
and location of the common domains used to generate polyclonal antibodies against all Rpgr
 
variants 
(RCC1 and S1) and the ORF15 specific domain used to generate our polyclonal ORF15 antibody.  (B) 
Immunoblot analysis of retinal homogenate from wild-type mice at postnatal day 3, 7, 14 and at 2 months.  
The Rpgr
ORF15
 variants are approximately 250kD and the Rpgr
ex1-19
 variants are roughly 100kD.  Retinal 
homogenate from Rpgr
-/-
 mice is shown at left to illustrate antibody specificity.  The faint smaller bands 
detected in the negative control are the result of antibody background and are not detected by any of our 
other antibodies against Rpgr.  (C) Graph illustrating relative expression of Rpgr
ex1-19
 and Rpgr
ORF15 
 in the 
developing retina. 
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Figure 2.3.  Immunohistochemical analysis of Rpgr
ex1-19
 and Rpgr
ORF15
 expression and localization in the 
developing retina and schematic representation of photoreceptor development at the analyzed time points.  
(A) Double immunostaining of retinal cryosections using our rabbit polyclonal anti-S2 antibody to detect 
Rpgr
ex1-19
 specific variants (top) and our guinea pig polyclonal anti-ORF15 antibody to detect Rpgr
ORF15
 
specific variants (upper middle).  Nuclear staining with DAPI (lower middle) and DIC images (bottom) are 
shown to monitor the developmental progression of the retina.  (B) Illustration representing the 
development of photoreceptor cells with representative expression and localization of Rpgr
ex1-19
 and 
Rpgr
ORF15
 variants. 
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Subcellular distribution of Rpgr variants in retina 
 
The N-terminal domain common to both Rpgr
ex1-19
 and Rpgr
ORF15
 interacts with Rpgrip, 
a structural component of the ciliary axoneme(50).  This interaction anchors Rpgr to the 
connecting cilia of rod and cone photoreceptors.  Upon fractionation of retinal tissue, 
Rpgr is present in the insoluble, ciliary axoneme enriched fraction in addition to the 
cytosolic fraction(50).  Ciliary localization of all Rpgr variants is lost in Rpgrip null 
mice, hence eliminating Rpgr from the insoluble fraction (Fig. 2.4A).  
 
 
 
Figure 2.4.  Fractionation of retinal homogenate illustrates ciliary localization of Rpgr variants.  (A) 
Fractionation of retinal homogenate from Rpgrip 
-/-
 retina shows failure of both Rpgr
ex1-19 
and Rpgr
ORF15
 
variants to properly localize to the connecting cilia.  S, soluble protein fraction; DS, NP40 detergent 
soluble fraction; IS, NP40 detergent insoluble fraction.  (B) Immunoblot of fractionated retinal 
homogenate from C57BL/6 wild-type mice.  Rpgr is normally distributed between the soluble fraction 
(unbound Rpgr) and the NP40 insoluble fraction (Rpgrip bound Rpgr) with a higher proportion of 
Rpgr
ORF15
 in the NP40 insoluble fraction. 
 
 
To examine whether both Rpgr variants share equal affinity toward Rpgrip in the 
connecting cilia, we fractionated retinal homogenates from 2 month old mice.  The 
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cytosolic fraction (soluble, S), the detergent soluble fraction (Nonidet P-40 soluble 
fraction, DS) and insoluble (IS) fraction were analyzed by immunoblot analysis using 
our polyclonal anti-S1 antibody (Fig. 2.4B).  γ-tubulin and synaptotagmin were used as 
quality controls to insure that the detergent soluble and insoluble fractions were enriched 
for the membrane bound and ciliary axoneme bound proteins, respectively.  Although 
the amounts of the Rpgr
ex1-19
 and Rpgr
ORF15
 variants in the soluble fraction are 
approximately equal, a larger percentage of the total Rpgr
ORF15
 isoform population was 
found in the insoluble fraction.  These results indicate that the two groups of variants do 
not share equal affinity for the ciliary fraction. 
 
Expression of Rpgr
ex1-19
 and Rpgr
ORF15
 in transgenic mice 
Rpgr
ex1-19
 and Rpgr
ORF15
 variants both interact with Rpgrip and thus likely share some 
functional redundancy.  However, the discrete C-terminal domains, evidence of 
developmental differences in isoform expression, and differential binding to the 
axoneme suggests that the two Rpgr variants also possess independent functions.  To 
investigate the unique role of these two groups of variants in photoreceptor viability, we 
produced transgenic mice expressing only Rpgr
ex1-19
 or Rpgr
ORF15
.   The mRDef 
transgenic mice express a full length Rpgr
ex1-19
 transcript with an N-terminal 3x Myc tag.  
This construct (Fig. 2.5A) is expressed from a CMV/-actin promoter (CBA), which 
drives expression in both rods and cones(60,76)(see Methods).  This line was examined 
in both a wild-type and Rpgr null background, herein referred to as mRDef
Rpgr wt 
and 
mRDef
Rpgr -/-
, respectively.  The mROrf transgenic mice likewise express an Rpgr
ORF15
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Figure 2.5.  Schematic illustration of transgenic constructs and confirmation of transgene expression.  (A) 
Top: A Rpgr
ex1-19
 transcript was cloned between the cytomegalovirus (CMV) enhancer β-actin promoter 
(CBA) and a bovine growth hormone (BGH) polyadenylation sequence.  Bottom: A full length Rpgr
ORF15
 
transcript was cloned from a combination of genomic and cDNA.  Exons 1-13 were cloned from wild-type 
retinal cDNA and the final exon, ORF14/15, was cloned from genomic cDNA.  An N-terminal Myc tag 
was integrated in both transgenic constructs to allow for differentiation between transgenic and native 
Rpgr expression.  (B) Left: Immunoblot analysis of retinal homogenate from wild-type and Rpgr
-/-
 mice 
using our polyclonal anti-S1 and monoclonal anti-myc antibodies.  Middle: Verification of transgene 
expression by immunoblot analysis of retinal homogenate from mRDef
Rpgr-/-
 transgenic mice.  Right: 
Verification of transgene expression by immunoblot analysis of retinal homogenate from mROrf
Rpgr-/-
 
transgenic mice.  (C) Comparison transgenic expression levels with Rpgr expression in wild-type retina by 
immunoblot analysis using the anti-S1 antibody. 
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construct from a CBA promoter and includes an N-terminal 3x Myc tag (Fig. 2.5A).  
This line was examined in an Rpgr
-/-
 background, herein referred to as mROrf 
Rpgr -/-
. 
 
To confirm that the promoter was driving expression of the transgene in the retina, we 
analyzed retinal homogenate from mRDef
Rpgr -/-
and mROrf 
Rpgr -/-
transgenic mice by 
immunoblot analysis.  Expression was first confirmed using the S1 antibody followed by 
a monoclonal anti-myc antibody.  An immunoblot of retinal homogenate from wild-type 
and Rpgr
-/-
 mice verified the specificity of our antibodies (Fig. 2.5B).  The presence of 
the N-terminal 3X-Myc tag increased the size of the transgenic Rpgr
ex1-19
 protein by an 
estimated 27kD.  Although the transgenic Rpgr
ORF15
 protein has the same N-terminal tag, 
the increase in size is not evident due to decreased separation of proteins larger than 
~250 kDa on the gel. 
 
To estimate the expression level of the transgenic protein, we compared serial dilutions 
of retinal homogenate from mRDef
 Rpgr -/-
 and mROrf
 Rpgr -/-
 transgenic mice with retinal 
homogenate from wild-type mice (Fig. 2.5C).  By comparing the 10, 20 and 40 fold 
dilutions, we estimate there is approximately an 80-fold increase in Rpgr
ex1-19
 expression 
and about a 40-fold increase in Rpgr
ORF15 
expression in our transgenic mice in 
comparison to wild-type Rpgr expression levels. 
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Localization of transgenic Rpgr protein variants  
Using immunofluorescence microscopy, we previously determined that Rpgr is 
concentrated in the connecting cilia of rod and cone photoreceptors(54), as is shown in 
Figure 2.6A.  To examine the subcellular localization of transgenic Rpgr proteins, we 
compared frozen retinal cryosections from mRDef
 Rpgr -/-
 and mROrf
 Rpgr -/-
 mice with 
retinal sections from wild-type mice.  All retinal sections were probed with both the S1 
antibody and a monoclonal anti-myc antibody (Fig. 2.6).  Unlike wild-type Rpgr 
staining, which localizes to the connecting cilium, Rpgr staining in the mRDef
 Rpgr -/-
 
transgenic mice not only labels the connecting cilia but extends into the inner and outer 
segments (Fig. 2.6B).    In the mROrf
 Rpgr -/-
 transgenic mice, Rpgr was observed in the 
connecting cilia and inner segment but not in the outer segment (Fig. 2.6C).  This data 
confirms that both lines express transgenic Rpgr in photoreceptors, and that 
overexpression of different Rpgr variants results in protein mislocalization.  However, 
only overexpression of Rpgr
ex1-19
 resulted in protein accumulation in the outer segment. 
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Figure 2.6.  Comparison of native Rpgr localization with Rpgr 
ex1-19
 and Rpgr 
ORF15
 transgenic expression 
by immunohistochemical analysis of frozen retinal cryosections.  (A) Double staining of wild-type retina 
with our anti-S1 polyclonal antibody (red) and anti-myc monoclonal antibody (green).  (B) Double 
staining of transgenic Rpgr
ex1-19
 expression in mRDef
 Rpgr -/-
 retina with the anti-S1 antibody (red) and anti-
myc antibody (green).  (C) Double staining of transgenic Rpgr 
ORF15
 expression in mROrf
 Rpgr -/-
 retina with 
the anti-S1 antibody (red) and anti-myc antibody (green). 
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To gain better resolution of protein localization, we co-labeled mechanically dissociated 
photoreceptors for Rpgr and rootletin, a structural component of the inner segment..  
These preparations contained mostly shaken-off rod outer segments attached to the 
connecting cilia with a portion of the inner segments at the proximal end of the 
connecting cilia.  Comparison of the immunofluorescence and DIC images of a wild-
type photoreceptor confirms Rpgr localization to the connecting cilium (Fig. 2.7A).  A 
schematic diagram of a photoreceptor cell is shown in Figure 2.7B to help illustrate the 
subcellular compartments.  The staining pattern of Rpgr
ORF15
 in mROrf
 Rpgr -/- 
dissociated 
photoreceptors strongly resembles labeling of Rpgr in wild-type photoreceptors.  
However, comparison of immunolabeled Rpgr
ex1-19
 in mRDef
 Rpgr -/-
 photoreceptors 
shows intense outer segment staining in addition to the normal ciliary staining (Fig. 
2.7A).  This data is consistent with our immunofluorescence staining of retinal sections 
(Fig. 2.6) and confirms that overexpression of Rpgr
ex1-19
 results in an atypical 
accumulation of protein in the photoreceptor outer segments.   
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Figure 2.7.  Comparison of the subcellular distribution of Rpgr in photoreceptors from wild-type and 
transgenic retina.  (A) Top: Double staining of a rod photoreceptor from wild-type retina anti-S1 and 
Rootletin antibody.  Middle: Double staining of a rod photoreceptor from mRDef
 Rpgr -/-
 transgenic retina 
with anti-S1 and Rootletin antibody.  Bottom: Double staining of a rod photoreceptor from mROrf
 Rpgr -/-
 
transgenic retina with anti-S1 and Rootletin antibody.   (B) Schematic representation of a rod 
photoreceptor illustrates subcellular compartments.  (C)  Fractionation of retinal homogenate from wild-
type retina and mRDef 
Rpgr-/-
 retina shows accumulation of excess Rpgr
ex1-19
 protein in the membrane 
bound fraction.  S, soluble protein fraction; NS, NP40 detergent soluble fraction; IS, NP40 detergent 
insoluble fraction.  Left: Immunoblot of fractionated retinal homogenate from wild-type mice.  Rpgr is 
normally distributed between the soluble fraction (unbound Rpgr) and the NP40 insoluble fraction (Rpgrip 
bound Rpgr).  Right: Immunoblot of fractionated retinal homogenate from mRDef
 Rpgr -/-
 mice shows 
accumulation of default protein in the membrane bound, NP40 soluble fraction.  (D) Double staining of 
rod photoreceptors from mRDef transgenic mice in a wild-type background.  Top: Double staining of all 
Rpgr variants (anti-S1) and Rootletin (anti-Root6).  Bottom: Double staining of only the Rpgr 
ORF15
 
variants (anti-ORF15) and Rootletin. 
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The C-terminus of the Rpgr
ex1-19
 peptide contains an isoprenylation signal and is 
isoprenylated in tissue culture
1, 9, 22
.  As isoprenylation often facilitates binding of 
proteins to target membranes(77,78), we hypothesized that excess Rpgr
ex1-19
 accumulates 
in the outer segments of mRDef photoreceptors due to interactions with the disc 
membranes.  To test this hypothesis, we compared fractionated retinal homogenate from 
mRDef
 Rpgr -/-
 and wild-type mice (Fig. 2.7C).  In the wild-type retina, Rpgr
ex1-19
 is 
primarily found in the cytosolic (S) and ciliary axoneme enriched (IS) fractions.  In the 
mRDef retina, there is a moderate increase in the presence of Rpgr
ex1-19
 in both the 
cytosolic (S) and ciliary axoneme enriched (IS) fractions.  However, the most significant 
change is the accrual of protein in the detergent soluble fraction (NS).  Since Nonident 
P-40 solubilizes membrane-bound proteins, we conclude that Rpgr
ex1-19
 accumulates in 
the outer segments by interacting with the membranes.   
 
Since Rpgr
ex1-19
 and Rpgr
ORF15
 compete for interaction with Rpgrip in the photoreceptor 
connecting cilia, we also examine whether an increase in the Rpgr
ex1-19
 concentration 
disrupts localization of Rpgr
ORF15
 to the connecting cilia.  We labeled dissociated 
photoreceptors from transgenic mRDef mice in a wild-type Rpgr background for all 
Rpgr variants (anti-S1) and only Rpgr
ORF15
 (anti-ORF15) (Fig. 2.7D).  Photoreceptors 
were also labeled with anti-rootletin to confirm the location of subcellular 
compartments.  Despite the overabundance and mislocalization of Rpgr
ex1-19
, localization 
of native Rpgr
ORF15
 to the photoreceptor connecting cilia remained unaltered.  If Rpgr
ex1-
19
 and Rpgr
ORF15
 share equal affinity for Rpgrip, then we would expect the excess 
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Rpgr
ex1-19
 protein to compete for Rpgrip and diminish the ciliary presence of Rpgr
ORF15
; 
however, this was not observed.  This is consistent with our earlier findings that a larger 
proportion of Rpgr
ORF15
 than Rpgr
ex1-19
 is found in the ciliary-enriched fraction (Fig. 2.4) 
and supports our conclusion that Rpgr
ORF15
 has a higher affinity for binding Rpgrip in 
the connecting cilia. 
 
Retinal disease in Rpgr
ex1-19
 transgenic mice  
To evaluate the effects of transgene expression on photoreceptor cell survival, we 
examined retinal morphology in wild-type mice at 2 months of age and mRDef
 Rpgr -/-
 
mice between 2 and 8 months of age (Fig. 2.8A-D).  Although the retinal morphology of 
mRDef
 Rpgr -/-
 mice was comparable to that of wild-type at the completion of retinal 
development (P21), retinal cell loss was apparent in young mRDef 
Rpgr -/-
 retinas.  By two 
months of age, the inner and outer segments of the mRDef
 Rpgr -/-
 mice were shortened, 
and a decreased number of nuclei in the outer nuclear layer provided evidence of 
significant photoreceptor cell loss (Fig. 2.8B).  Compared to Rpgr
-/-
 mice (Fig. 2.8F), in 
which retinal cell loss is relatively slow(54), degeneration in mRDef mice was rapid 
with complete loss of photoreceptors by 8 months (Fig. 2.8D).  Since the rate of 
degeneration was similar in both Rpgr
-/-
 and wild-type backgrounds (Fig. 2.8D-E), we 
conclude that retinal cell loss results from the overexpression of Rpgr
ex1-19
 transgene.   
 
To investigate whether concurrent overexpression of Rpgr
ORF15
 would alter the mRDef 
transgenic phenotype, we bred mRDef and mROrf mice together in an Rpgr
-/-
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background.  We compared the retinal morphology of mRDef
 Rpgr -/-, 
mROrf
 Rpgr -/- 
and 
mRDef/mROrf
 Rpgr -/-
 littermates at 4 months of age (Fig. 2.8G-I), and found that the  
severity of the mRDef transgenic phenotype was unaffected by the presence of 
Rpgr
ORF15
.    Thus, we conclude that the retinal cell loss in mRDef transgenic mice 
results in a neomorphic phenotype independent of Rpgr
ORF15
 expression.  
 
 
Figure 2.8.  Phenotypic analysis of mRDef transgenic mice using light microscopy.  (A-I)  Histological 
section of wild-type retina at 2 months.  RPE, retinal pigment epithelium; ONL, outer nuclear layer; INL, 
inner nuclear layer; GC, ganglion cell layer.  (B-D) Histological sections of mRDef
Rpgr-/-
 at 2-8 months of 
age. (E)  Histological sections of mRDef
Rpgr wt
 at 8 months of age.  (G-I) mRDef 
Rpgr -/-
 mice were crossed 
with mROrf 
Rpgr -/-
 mice and the retinal phenotypes of 4 month old single and double transgenic littermates 
were assessed by light microscopy at 4 months of age. 
  
45 
 
Mislocalization of cone opsins in cone photoreceptor cell bodies and synapses is a 
prominent phenotype in Rpgr
-/-
 mouse retinas before retinal cell loss is even 
apparent(54).  Both blue and green cone opsins, which normally localize in the outer 
segments, partially mislocalize to the inner segment, perinuclear area, and synaptic 
regions as early as postnatal day 20 in Rpgr
-/-
 mice (data not shown)(54).  To observe 
whether expression of Rpgr
ex1-19
 or Rpgr
ORF15
 rescues the phenotype in cone 
photoreceptors, we compared mRDef 
Rpgr -/-
, mROrf 
Rpgr -/-
 and wild-type control retinas 
by immunofluorescence for cone opsin (Fig. 2.9A).  Like Rpgr
-/-
 retinas(54), opsins in 
the mRDef 
Rpgr -/-
 cone photoreceptors show mislocalization in the inner segment, 
perinuclear regions and synaptic terminals.  In contrast, cone opsin staining in the 
mROrf 
Rpgr -/-
 was confined to the cone OS, as in wild type, indicating restoration of Rpgr 
function in cone cells.  Thus, comparison of the number and integrity of cone cells 
between the two transgenic mice demonstrates that Rpgr
ORF15
 but not Rpgr
ex1-19
 is able to 
rescue the Rpgr
-/-
 phenotype. 
 
Upregulation of glial fibrillary acidic protein (GFAP) expression in the retina is a 
nonspecific marker of retinal degeneration.  In Rpgr
-/-
 retinas, GFAP upregulation 
indicates degenerative changes prior to retinal cell loss(54).   As an additional outcome 
measure for the mRDef 
Rpgr -/-
 and mROrf 
Rpgr -/-
 transgenic phenotypes, we examined 
GFAP expression in transgenic and control animals (Fig. 2.9B).  As expected, GFAP 
was clearly unregulated in the mRDef
 Rpgr -/-
 mice with expansion of staining into the  
 
  
46 
 
 
 
Figure 2.9.  Mislocalization of opsins and up-regulation of GFAP in mRDef transgenic mice.  (A-B) RPE, 
retinal pigment epithelium; ONL, outer nuclear layer; INL, inner nuclear layer; GC, ganglion cell layer.  
(A) Immunohistochemical analysis of opsin localization in retinal cryosections using green cone opsin 
specific antibody.  Left: wild-type retina;  Middle: mRDef
 Rpgr -/-
 transgenic retina;  Right: mROrf 
Rpgr -/-
 
transgenic retina (B) Upregulation of GFAP immunoreactivity in mRDef
 Rpgr -/-
 retina.  Left: wild-type 
retina;  Middle: mRDef
 Rpgr -/-
 transgenic retina;  Right: mROrf 
Rpgr -/-
 transgenic retina. 
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outer retina.  Virtually no GFAP signal was detected in the wild-type and mROrf
 Rpgr -/- 
retinas. 
 
Because of the rate of degenerative changes and the aforementioned accumulation of 
Rpgr
ex1-19
 protein in the outer segments of mRDef
 Rpgr -/-
 transgenic mice, photoreceptor 
outer segment morphology was assessed by electron microscopy at 2 months of age Fig. 
2.10).  The outer segments were notably disorganized in the transgenic mice with 
disruption of the conventional parallel arrangement of disk membranes and poorly 
defined outer segment morphologies.  Perimeters were undefined and disk diameters to 
the long axis of the outer segments instead of the normal perpendicular orientation.  
Although such defects are not seen in the Rpgr
-/-
 mice, these observations are 
reminiscent of the abnormal disk morphology seen in the Rpgrip
-/-
 mice(51).   
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Figure 2.10.  Ultrastructural examination of photoreceptor outer segments in mRDef transgenic mice.  (A) 
Digital TEM images at 11,000X.  Left: TEM image of photoreceptor outer segments in two month old 
Rpgr 
-/-
 retina.  Right: TEM image of photoreceptor outer segments in two month old mRDef
 Rpgr -/-
 retina.  
(B) Digital TEM images at 44,000X.  Left: TEM image of photoreceptor outer segments in two month old 
Rpgr 
-/-
 retina.  Right: TEM image of photoreceptor outer segments in two month old mRDef 
Rpgr -/-
 retina.  
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Discussion 
An important finding of this work is the differential regulation of Rpgr variant 
expression during photoreceptor development.  Although previous analyses of mice 
lacking Rpgr indicated that Rpgr is not essential for mammalian photoreceptor 
development(54), the robust expression of the Rpgr
ex1-19
 variant during retinal 
development is nonetheless suggestive of a functional role in cellular development.  
These conclusions are consistent with a recent report identifying two Rpgr orthologs in 
zebrafish, which were also reported to have more widespread expression during 
development.  Like many zebrafish orthologs of human genes, the two homologous 
RPGR genes reported (zfrpgr1  and zfrpgr2) are probably attributed to a genome 
duplication that occurred in teleosts.  Unlike mammals, Rpgr knockdown in zebrafish 
results in developmental abnormalities, including failure to develop photoreceptor outer 
segments(65), suggesting that Rpgr is required for normal retinal development.  In 
addition, our data also indicates that emergence of the Rpgr
ORF15
 variants follows a 
reciprocal expression pattern, coinciding with photoreceptor maturation.  This supports 
the idea that Rpgr
ORF15
 plays a physiological role in the integrity of mature 
photoreceptors.  While it has been speculated that Rpgr
ORF15
 is the functionally 
significant variant in photoreceptors(60), the dynamics of Rpgr expression in emerging 
photoreceptors suggests that both the Rpgr
ORF15
 and Rpgr
ex1-19
 variants retain some 
independent, isoform specific functions. 
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In this study, we also address whether the Rpgr
ex1-19
 variant alone is able to restore 
function to photoreceptors lacking endogenous Rpgr.  Photoreceptors in Rpgr
ex1-19
 
transgenic mice exhibit atypical accumulation and interaction of Rpgr
ex1-19
 protein with 
the membranous outer segments, severe histopathological changes in the photoreceptor 
outer segments, mislocalization of cone opsin and up regulation of GFAP.  Expression of 
the Rpgr
ex1-19
 transgene results in a substantially more severe phenotype than that of the 
previously reported Rpgr
-/-
 mice(54) with photoreceptor degeneration apparent from an 
early age.   
 
Rpgr
ex1-19
 expression in our transgenic mice exceeds wild-type endogenous Rpgr
ex1-19
 
expression by several fold.  Thus, the observed phenotype may be a non-specific 
consequence associated with the intense level of overexpression.  However, since similar 
overexpression of the Rpgr
ORF15
 variant did not result in atypical accumulation of protein 
in the outer segment nor a degenerative retinal phenotype, we conclude that our report 
describes an Rpgr
ex1-19
 specific phenomenon.  Although endogenous Rpgr
ex1-19
 
expression in adult photoreceptors is minimal, further investigation of this acquired 
function, may nonetheless provide evidence of native Rpgr
ex1-19
 function in developing 
and/or mature photoreceptors. 
 
The Rpgr
ex1-19
 variant differs from the Rpgr
ORF15
 variant by the presence of a C-terminal 
isoprenylation motif (25,37,46,79). By immunofluorescence, we observe that excess 
Rpgr
ex1-19
 protein accumulates in photoreceptor outer segments.  Such mislocalized 
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accumulation is likely related to the membranous nature of the outer segment structure 
and the inherent properties of the isoprenylation signal.  In general, isoprenylation motifs 
signal the addition of prenyl groups at carboxy-terminal cysteine residues.  The 
functional consequence of such posttranslational protein modification is anchorage of 
prenylated proteins to cell membranes(77,78).   
 
Given evidence of severely diminished Rpgr
ex1-19
 expression in mature photoreceptors 
and the affinity of Rpgr
ex1-19
 to tightly bind Rpgrip in the connecting cilia(44,45,50), the 
presence of Rpgrip is likely sufficient to limit localization of endogenous Rpgr to the 
connecting cilia in mature photoreceptors.  This would suggest that if the concentration 
of Rpgr
ex1-19
 exceeds the binding capacity of Rpgrip or if binding is otherwise 
interrupted, default may begin to mislocalize and accumulate in the photoreceptor outer 
segments.  By electron microscopy, it is clear that this accumulation of protein both 
functionally and morphologically disrupts the organized structure of the outer segments‟ 
membranous disks.  In addition, isoprenylation of Rpgr may be required for some form 
of ciliary trafficking during very early stages of photoreceptor development before the 
appearance of the outer segments.  Thus, the Rpgr
ex1-19
 variants may possess different 
functions during early development as compared to the function of Rpgr
ORF15
 following 
ciliogenesis and outer segment maturation.   
 
Although we have previously shown that expression of a single Rpgr
ORF15
 variant 
substantially rescues the Rpgr knockout phenotype(60) , these more recent findings 
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should also be taken into consideration when designing therapeutic treatment for RPGR 
patients.  Unfortunately, there is a void in knowledge regarding protein expression in 
RPGR patients.  Although a majority of RPGR mutations are in the ORF15 exon and 
thus only directly affect the integrity of the Rpgr
ORF15 
variants, there is some possibility 
of indirect effects on Rpgr
ex1-19
 expression as well.  Given that all RPGR variants are 
under the control of a single promoter there exists some possibility that Rpgr
ex1-19 
expression may be affected by endogenous attempts to compensate for the loss of 
functional Rpgr
ORF15
.  This theory may explain some of the variability associated with 
human genotype-phenotype correlation, as well as, the surprisingly mild phenotype of 
Rpgr null mouse models when compared with XlRP3-affected humans and dogs.  
Furthermore, if this theory is upheld, then introduction of the Rpgr
ORF15 
variant by gene 
therapy also has the potential to affect endogenous Rpgr expression.  In either case, up-
regulation of Rpgr
ex1-19 
expression has the potential to be more detrimental to 
photoreceptor integrity and disease progression than the lack of functional Rpgr
ORF15
. 
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CHAPTER III 
 
RPGR
ORF15
 CONNECTS TO THE USHER PROTEIN NETWORK THROUGH 
DIRECT INTERACTIONS WITH MULTIPLE WHIRLIN ISOFORMS 
 
Overview 
Mutations in the retinitis pigmentosa GTPase regulator (RPGR) gene account for more 
than 70% of the cases of X-linked Retinitis Pigmentosa.  RPGR undergoes complex 
alternative splicing to express both constitutive and ORF15 variants, and the latter have 
been reported to be functionally significant in the maintenance of photoreceptor 
viability.   While functional studies of RPGR suggest a role in intracellular protein 
trafficking across the connecting cilia, the function of RPGR is not well understood and 
little is known about functional binding partners.  In this study, we show that the C-
terminus of RPGR
ORF15
 binds whirlin, a PDZ-domain scaffold protein and known 
member of the Usher protein network.  RPGR
ORF15
-whirlin interaction was confirmed 
using in vitro binding assays and co-immunoprecipitation from retinal tissue, and both 
proteins were shown to co-localize in the photoreceptor connecting cilia in vivo.  Our 
data also demonstrate that whirlin expresses multiple isoforms in photoreceptors with 
variable subcellular localization. Whirlin expression has previously been reported in 
photoreceptors and cochlear hair cells, and mutations in whirlin cause Usher syndrome 
(USH2D) and non-syndromic congenital deafness (DFNB31).  Since mutations in the 5‟-
end of whirlin are associated with the syndromic phenotype associated with USH2D, the 
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identification of novel N-terminal isoforms in the retina and a novel RPGR
ORF15
-whirlin 
interaction provide a potential mechanism for the retinal phenotype observed in USH2D. 
 
Introduction 
X-linked retinitis pigmentosa (XLRP) represents the most severe class of Retinitis 
Pigmentosa (RP), a group of inherited diseases causing progressive retinal degeneration 
(25,26).  RP is characterized by night blindness, progressive loss of visual fields, and 
eventual blindness, all of which result from photoreceptor cell death and accumulation of 
intra-retinal pigment-like deposits (18).  Mutations in the retinitis pigmentosa GTPase 
regulator (RPGR) gene account for more than 70% of XLRP and approximately 10% of 
all RP cases (20,25,26).
 
 Ablation of the Rpgr gene in mice (54) and naturally occurring 
mutations in dogs (64) also cause photoreceptor cell degeneration, suggesting that 
photoreceptor survival requires RPGR.  In addition, evidence of early cone 
photoreceptor defects indicates that RPGR is necessary for the survival of both types of 
photoreceptors (30,54,66).  
 
RPGR transcripts undergo complex alternative splicing to generate default and 
RPGR
ORF15
 transcripts (26,37,67,68)
 
(Fig. 3.1A-B).   Default variants are widely 
expressed and contain nineteen exons (RPGR 
ex1-19
), while the RPGR
ORF15
 variants are 
preferentially expressed in the retina and contain exons 1-13 plus a large, alternatively 
spliced C-terminal exon 14/15 (26,54).  Both variants share a common N-terminal 
domain, however, their remaining C-terminal domains vary considerably (25,26,54).  
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The presence of disease-causing mutations within the ORF15 exon suggests that 
RPGR
ORF15
 variants are functionally significant (26). 
 
RPGR localizes to the photoreceptor connecting cilium (37,52,54).  One of the primary 
defects in mice lacking RPGR is cone opsin mislocalization in photoreceptors
 
(54).  
Although this suggests that RPGR regulates protein trafficking through the connecting 
cilia, the function of RPGR is poorly understood and little is known about physiological 
binding partners. 
 
To further investigate the in vivo function of RPGR, we used a yeast two-hybrid screen 
to identify potential interacting partners of RPGR
ORF15
.  We identified a novel N-
terminal variant of whirlin, a putative PDZ scaffold protein expressed in cochlear hair 
cells and retinal photoreceptors.  Whirlin is a member of the Usher protein network, a 
dynamic complex  which includes motor proteins, scaffold proteins, cell adhesion 
molecules and transmembrane receptors critical for development and maintenance of 
these sensorineural cells (80-86).  Mutations in the DFNB31/WHRN gene encoding 
whirlin cause the non-syndromic deafness DFNB31 and Usher Syndrome, Type 2D 
(USH2D), an autosomal recessive condition characterized by congenital deafness and 
RP (87,88).  The direct association between whirlin and RPGR
ORF15
 provides a novel 
mechanism for RP in USH2D. 
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Figure 3.1.  Illustration of the RPGR and whirlin/DFNB31 gene structures and analysis of whirlin 
expression in the mouse retina at the RNA level.  (A) Schematic representation of the RPGR gene 
structure.  Alternative splicing leads to two groups of RPGR transcripts; RPGR default includes exons 1-
13 and exons 16-19 while RPGR
ORF15
 includes exons 1-13 plus a large, alternatively spliced ORF 14/15.  
Orange, exons encoding RCC1-like domain common to all RPGR isoforms; green, remainder of exons 
common to all RPGR isoforms; blue/purple, exon (ORF 14/15) unique to RPGR
ORF15
; purple, alternatively 
spliced region of ORF14/15 encoding glutamic acid-rich domain.  (B) Illustration of the RPGR
ORF15
 
isoform.  All colors correspond to their respective exons in shown Fig. 1A.  Brackets indicate the location 
of domain used as bait in the yeast two-hybrid screen.  (C) Schematic representation of the 
whirlin/DFNB31 gene structure.  Whirlin is composed of 13 exons encoding three PDZ domains and a 
proline-rich region.  Exons and encoded domains are drawn approximately to scale.  PCR primers used for 
amplification of whirlin transcripts are shown as red arrows.  (D) Amplification of whirlin N-terminal 
transcripts from C57BL/6 retinal cDNA.  Left/Center: Whirlin mRNA transcripts were reverse transcribed 
and amplified using primers shown in Fig. 2A.  The whirlinNT1 transcript, which includes intron 3, was 
amplified by WiP1 and WiP14R, and the whirlinNT2 transcript, which includes intron 7, was amplified by 
WiP1 and Wi_intron7_P1R.  Right: Whirlin N-terminal transcripts were also amplified by nested PCR of 
3‟RACE retinal cDNA.  Transcripts were first amplified using WiP1 and GeneRacer 3‟ Primer followed 
by WiP2 and GeneRacer 3‟ Nested Primer.  The regions excised and used to clone and sequence the 
whirlinNT1 and whirlinNT2 transcripts are indicated by the red brackets. 
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Experimental procedures 
Animals 
C57BL/6 mice were obtained from Harlan Laboratories (Houston, TX) and the RPGRIP 
knockout mice were generated by targeted disruption of the RPGRIP gene as previously 
described (51).  All animals were maintained on a 12-h light – dark cycle, with food and 
water ad libitum and were handled in accordance with the institutional guidelines as 
approved by the Texas A&M University IACUC (Institutional Animal Care and Use 
Committee).  Whirlin knockout retina were a gift from Jun Yang, (Moran Eye Center, 
Salt Lake City, Utah). 
 
Yeast two-hybrid analysis 
Yeast two-hybrid screening was performed using the GAL4-based two-hybrid system.  
Cloning vectors, yeast host cells and reagents were purchased from CLONTECH 
Laboratory (Palo Alto, CA).  A retinal cDNA library was constructed from poly(A)+ 
RNA from C57BL/6 mouse retinas, and the cDNAs were inserted into the pACT2 
plasmid vector downstream from the GAL4 activation domain.  The bait plasmid was 
constructed by inserting a cDNA encoding the bait protein into the pGBKT7 plasmid 
vector downstream from the GAL4 DNA binding domain.  The bait protein consisted of 
the C-terminus of mouse RPGR
ORF15
 (amino acids 679-781).  Reference to the 
numbering of exon ORF15 of the RPGR
ORF15
 sequence in this report is based on 
GenBank accession, HQ260316.  A sequential transformation protocol was used to 
introduce bait and library plasmids into yeast.  Yeast AH109 cells were first transformed 
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with the bait plasmid, and the bait protein expression was verified by immunoblot.  
Competent cells were then prepared from a yeast clone harboring the bait plasmid and 
transformed with the library plasmids.  Positive colonies were isolated based on their 
ability to express nutritional markers HIS3 and ADE2 and the lacZ reporter, driven by 
different Gal4-responsive promoters to minimize false positives due to fortuitous 
activation of a particular promoter.  Candidate plasmids were sequenced on an ABI 3100 
Automated Sequencer. 
 
Reverse transcription-polymerase chain reaction (RT-PCR)  
Total RNA was prepared from mouse retina using TRIzol reagent (Invitrogen), and RT-
PCR was performed using the SuperScript III RT-PCR kit (Invitrogen) according to the 
manufacturer‟s instructions.  PCR reactions were performed with PfuUltra II Fusion HS 
DNA Polymerase (Stratagene).  WiP1 (5‟-ATGAACGCACAGCTGGACGGC-3‟) and 
WiP4R (5‟-CTGATAGCCCTGAACTTGGCC-3‟) primers were used to amplify the full 
length whirlin transcript.  WiP1 and WiP14R (5‟-
CAGTAGTTGCATCAAAACATTAGCTGCC-3‟) primers were used to amplify the 
whirlin NT1 transcript.  WiP1 and Wi_intron7_P1R primers were used to amplify the 
whirlin NT2 transcript.  The locations of all primers are illustrated in Fig. 3.1C.  PCR 
products were gel purified and cloned using the StrataClone Ultra Blunt PCR Cloning 
Kit (Stratagene). 
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3’ rapid amplification of cDNA ends 
Total RNA was prepared from mouse retina using TRI reagent (Sigma Aldrich).  RT-
PCR was performed using the Generacer
TM
 Kit purchased (Invitrogen) as per the 
manufacturer‟s instructions.  Whirlin transcripts were amplified by nested PCR using 
whirlin specific 5‟ primers (WiP1 and WiP2, 5‟-AGCTGCTCTTGCACCAGTACACG-
3‟) and the GeneRacer 3‟ Primer and GeneRacer 3‟ Nested Primer.  For cloning, 3‟ 
RACE products were gel purified and ligated using the Zero Blunt® TOPO® PCR 
cloning kit (Invitrogen). 
 
Cell culture and transfection 
AAV293 cells were maintained in Dulbecco‟s modified Eagle medium (DMEM) 
supplemented with 5% fetal bovine serum, penicillin (100 U/ml) and streptomycin 
(130ug/ml) at 37°C in an atmosphere of 5% CO2.  Transient transfection was performed 
using the standard calcium phosphate method.  Transfected cells were washed once with 
PBS and were homogenized in 50mM Tris, pH 7.4, 150mM NaCl, 0.5% NP40.  The cell 
lysates were cleared by centrifugation at 12,000 X g for 10 minutes, and the supernatants 
were used for subsequent immunoblot analysis or protein pull-down assays.   
 
Protein pull-down assays 
N-terminal MBP fusion proteins containing either the WhirlinNT1 variant (GenBank 
accession, HQ148552), the whirlin PDZ1 domain (amino acids 141-216; GenBank 
accession, NP_082916.1), the whirlin PDZ2 domain (amino acids 270-350), the region 
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between the two PDZ domains (amino acids 217-269), or MBP alone were expressed in 
Escherichia coli Rosetta cells using the pMALC2X expression vector (New England 
Biolabs).  To verify that equivalent amounts of the specific MBP-fusion proteins and 
MBP protein alone were used, purified protein was analyzed by Bradford assay and 
equal molar concentrations were calculated.  A single RPGR
ORF15
 transcript was 
obtained by RT-PCR using ORF15 specific primers and cloned using the Zero Blunt® 
TOPO® PCR cloning kit (Invitrogen).  After subcloning into a mammalian expression 
vector under the control of the CBA (CMV enhancer/chicken β-actin) promoter, the 
75kD isoform was expressed by transient transfection in HEK293 cells.  Increasing 
equimolar concentrations (0.625 mM, 1.875 mM, and 5.625 mM) of the MBP fusion 
proteins and MBP protein alone were immobilized on amylose resin and were incubated 
with HEK293 cell lysate expressing the 75kD RPGR
ORF15
 variant for 2 hours at room 
temperature with gentle rocking.  The beads were washed four times with binding buffer, 
resuspended as above and assayed using anti-S1 antibody. 
 
The C-terminal domain of mouse RPGR
ORF15
 (amino acids 679-781 of exon 14/15), 
which was used as bait in the yeast two-hybrid screen, was cloned into the pMALC2X 
expression vector (Invitrogen).  An N-terminal maltose binding protein fusion containing 
the ORF15 C-terminal domain and MBP alone were expressed in Rosetta Escherichia 
coli cells and purified.  Purified protein was quantified using a Bradford assay and 
equivalent molar concentrations were calculated.  cDNAs for expression of the 
whirlinNT1 and long whirlin isoforms were obtained by RT-PCR as described, and were 
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subcloned into pcDNA3.1(+)/3xMyc mammalian expression vector.   The full length 
whirlin and whirlinNT1 variants were expressed in HEK293 cells, and extracts were 
equalized by immunoblot analysis with anti-myc tag antibody.  Purified MBP fusion 
protein of increasing molar concentration (0.625 mM, 1.875 mM, and 5.625 mM) were 
immobilized on amylose resin and were incubated with equal amounts of full length 
whirlin and whirlinNT1 for 2 hours at room temperature with gentle rocking.  Purified 
MBP alone was used at the highest equimolar concentration (5.625mM) as a negative 
control.  The beads were washed four times with binding buffer (25mM Tris, pH 7.4; 
100mM NaCl; 1mM MgCl2; 0.1% NP40).  Bound proteins were resuspended in 30µl of 
2X SDS sample buffer with β-mercaptoethanol and analyzed by immunoblot analysis 
using anti-myc tag antibody. 
 
Co-immunoprecipitation 
Retinal homogenate from six week old RPGRIP knockout mice was incubated overnight 
at 4°C with either anti-S1 antibody or pre-inoculated rabbit serum.  The antibody-protein 
complex was immobilized on Dynabeads® Protein G (Invitrogen) following the 
manufacturer‟s instructions.  Co-immunoprecipitated protein was visualized by 
immunoblot using whirlin-specific primary antibody, which was conjugated to alkaline 
phosphatase for direct detection by chemiluminescence without subsequent incubation 
with a secondary antibody. 
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Antibodies 
Mouse whirlin fragments (WiNT, amino acids 1-322; WiCT, amino acids 670-907; 
GenBank accession, NP_082916.1) were inserted into the expression vector pMALC2X.  
Recombinant proteins were expressed as N-terminal MBP-fusion proteins in Escherichia 
coli Rosetta cells.  The recombinant proteins were purified on amylose resin and were 
used to immunize rabbits.  Whirlin-specific antibodies were affinity-purified from 
antisera against their respective immunizing antigens immobilized in an agarose bead 
column (Aminolink; Pierce).  Specificity of the antibodies was verified against 
Escherichia coli expressing fusion proteins and against whirlin cDNA clones transiently 
expressed in a mammalian expression system (HEK293).  The polyclonal ORF15 
antibody, generated by immunizing a guinea
 
pig with a glutathione S-transferase (GST) 
fusion protein encompassing
 
residues 140-228 of the mouse RPGR
ORF15
 exon, and the 
rabbit polyclonal S1 antibody, specific for residues 494-563 of all RPGR variants 
(GenBank accession, NP_001171421.1), have previously been characterized (50,69).   
Monoclonal rhodopsin antibody, rho-1D4, was a gift from Robert Molday, (University 
of British Columbia, Vancouver, British Columbia, Canada), and chicken anti-Rootletin 
antibody was previously published (89).  Primary antibodies raised in rabbit were 
detected with a goat anti-rabbit IgG-horseradish peroxidase conjugate (Pierce) and 
mouse monoclonal antibodies were detected with a  goat anti-mouse IgG-alkaline 
phosphatase conjugate (Pierce).  Alexa fluorochrome-conjugated secondary antibodies 
for immunostaining were employed (Molecular Probes, Inc). 
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Immunoblot analyses  
For immunoblot analyses, tissues were homogenized in buffer (50mM Tris, pH 7.4, 
150mM NaCl, 0.5% NP40) containing a protease inhibitor cocktail (Sigma Aldrich) and 
were centrifuged at 1000 X g for 2 minutes.  Whirlin full-length and short, N-terminal 
transcripts were subcloned into a pCDNA3.1 vector for mammalian protein expression 
and were transfected into HEK293 cells as described.  For denaturing gel 
electrophoresis, samples were mixed with 4X SDS sample buffer with β-
mercaptoethanol, were separated on 10% polyacrylamide gels and were transferred to 
PVDF membranes (Immobilon-P, Millipore).  After blocking the membrane in 5% skim 
milk in PBS with 0.1% Tween, immunoreactivities were detected by applying primary 
antibody overnight followed by the appropriate secondary antibody for 2 hours.  As a 
marker, a Precision Plus Prestained Standard (Biorad), ranging from 10 – 250kD to 
25kDa, was used. 
 
Immunohistochemistry  
For in situ detection of RPGR and whirlin, eyes were embedded in optimal cutting 
temperature (OCT) compound without fixation and were snap frozen in liquid nitrogen.  
Cryosections at 10-µm-thick were cut and collected on pretreated glass slides 
(Superfrost Plus; Fisher Scientific).  Sections were stored at -20°C and used within 2 to 3 
days.  Sections were briefly fixed in 4% paraformaldehyde prior to immunofluorescence 
staining, which was performed as previously described (50,54). 
 
  
64 
 
Dissociated Photoreceptors 
Dissociated photoreceptor fragments were obtained by mechanical detachment from 
freshly dissected mouse retinas, as previously described
 
(72).  In brief, retinas were 
suspended in Ringer Solution and were gently homogenized by five passes through a 
disposable transfer pipette.  Cell fragments were allowed to adhere for 5 minutes to 
pretreated glass slides (Superfrost Plus Microscope Slides; Fisher Scientific).  Adhered 
cell fragments were fixed for 5 minutes in ice-cold methanol, before proceeding with 
typical immunocytochemical staining as previously described (50,54). 
 
Results 
Identification of RPGR-whirlin interaction using the yeast-two hybrid system 
Since RPGR
ORF15
 is preferentially expressed in photoreceptors and appears to be the 
functionally significant RPGR variant (60), we hypothesized that identifying proteins 
interacting with the C-terminal domain would provide clues to the physiological 
significance of these isoforms.  We screened a C57BL/6 mouse retinal cDNA library by 
the yeast two-hybrid system, using the C-terminus of mouse RPGR
ORF15
 (mRPGR
ORF15
) 
(amino acids 1241-1343) as bait (Fig. 3.1B).  Of the 92 HIS3
-
, ADE2
-
 and lacZ-positive 
clones that were isolated and sequenced, 20 identical, independent clones coded for the 
N-terminal region of whirlin, suggesting that RPGR
ORF15
 interacts physically with 
whirlin.  We confirmed that the isolated library plasmid alone did not activate 
transcription of the reporter genes in yeast when transfected with a control bait protein. 
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Isolation of an N-terminal whirlin transcript by sequencing analysis of retinal cDNA 
Sequence analysis of the whirlin clone isolated from our yeast two-hybrid screen 
identified an N-terminal whirlin transcript.  The highly conserved whirlin gene, which 
comprises 13 exons, is already known to have multiple long and C-terminal short 
isoforms (see Table 1).  The long isoforms, which all have an estimated molecular 
weight of around 100kD, contain three PDZ domains (PDZ1, PDZ2 and PDZ3) and a 
proline-rich region.  There have been four variations of the long isoform reported 
(GenBank accession, NP_082916.1; NP_001008791.1; NP_001008792.1; 
NP_001008793.1).  The previously reported short C-terminal isoforms (GenBank 
accession, NP_001008794.1; NP_001008795.1; NP_001008796.1; NP_001008797.4; 
NP_001008798.1) are the result of variable splicing and multiple start codons in exons 6, 
7 and 8.  They contain only the PDZ3 domain and a proline-rich region (87,90) (Fig. 
3.1C).   
 
The N-terminal transcript identified by our yeast two-hybrid screen, which was recently 
detected at the transcript but not protein level (91), contains exons one through three 
followed by inclusion of the third intron and is the first known short N-terminal whirlin 
transcript.  Translation of this variant is expected to result in abrupt truncation of the 
protein at the beginning of intron three, resulting in a novel, short N-terminal whirlin 
isoform, subsequently referred to as whirlinNT1 (GenBank accession, HQ148552).   
To confirm the existence of this transcript in vivo, we reverse transcribed total RNA 
from C57BL/6 wild type retina, and subsequently amplified the resultant cDNA using 
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gene specific primers (Fig. 3.1C).  We were able to successfully amplify and clone this 
novel whirlin transcript from retinal cDNA.  In addition, we also performed 3‟ RACE on 
C57BL/6 wildtype retinal cDNA to confirm the existence of a mature mRNA transcript 
(Fig. 3.1D). 
 
Identification of other novel, N-terminal whirlin transcripts 
After identifying the novel whirlin transcript from our yeast two-hybrid screen, which is 
expected to generate a short, N-terminal whirlin isoform, we considered the possibility 
of other N-terminal variants.  Thus, we performed 3‟ RACE on C57BL/6 wild type 
retinal cDNA (Fig. 3.1D).  In addition to confirming the existence of the whirlinNT1 
transcript, we identified a second N-terminal whirlin transcript, designated whirlinNT2 
(GenBank accession, HQ148553).  The whirlinNT2 transcript includes exons 1 through 
6 followed by inclusion of intron 7, which results in truncation of the resultant peptide 
prior to the proline-rich domain (Fig. 3.1C).  The existence of this transcript was 
subsequently confirmed by PCR amplification of retinal cDNA (Fig. 3.1C-D). 
 
Confirmation of whirlin isoform expression at the protein level in the mouse retina 
The tissue specific expression of whirlin was examined by immunoblot analysis.  To 
confirm the existence of the whirlinNT1 and whirlinNT2 transcripts at the protein level, 
we raised a polyclonal antibody, designated anti-WiNT, designed to recognize the long 
whirlin isoform as well as any potential N-terminal short whirlin isoforms (Fig. 3.2A).  
In retinal extracts, this antibody detected the 110kDa, full-length whirlin isoform 
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(GenBank accession, NP_082916.1) previously reported (91) (Fig. 3.2B).  In addition, 
we detected two smaller variants around 85kDa and 60kDa and a fourth variant of 
approximately 34kDa (Fig. 3.2B).  To confirm that these variants were isoforms of 
whirlin, the whirlinNT1 and whirlinNT2 transcripts were cloned into a pcDNA3.1 vector 
and expressed in HEK293 cells (Fig.  3.2B).  The anti-WiNT polyclonal antibody 
recognized the whirlinNT1 and whirlinNT2 isoforms from these cell lysates (Fig. 3.2B) 
and the recombinant proteins matched the isoforms observed in retinal extracts.  These 
results confirm the existence of the two novel whirlin transcripts at the protein level and 
provide an extensive characterization of the N-terminal whirlin splice variants expressed 
in the mouse retina.  Despite extensive efforts, we were unable to identify a whirlin 
transcript corresponding to the 85kDa band.  Although we do not consistently detect this 
band in retinal extracts, it may be a degradation product, a different N-terminal isoform 
that we have not identified, non-specific antibody binding or an oligomer.  Given that 
whirlin has been reported to form homodimers (92), the latter is a probable explanation. 
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Figure 3.2.  Antibody maps for RPGR and whirlin, and analysis of whirlin expression in the mouse retina. 
(A) Top: Illustration of the RPGR
ORF15
 isoform structure and the location of domains used to generate 
polyclonal antibodies.  S1 antibody detects all RPGR isoforms; ORF15 detects only RPGR
ORF15
.  Bottom: 
Schematic representation of the whirlin long isoform structure and location of the domains used to 
generate polyclonal antibodies against the N-terminal and C-terminal ends.  WiNT detects the long whirlin 
isoform and any potential short, N-terminal isoforms; WiCT also detects the long whirlin isoform as well 
as the previously reported short, C-terminal isoforms.  (B-C) Characterization of whirlin antibodies and 
analysis of whirlin expression in the mouse retina and brain.  (B) Immunoblot analysis of retinal 
homogenate and cell lysate from HEK293 cells transfected with the designated whirlin isoform.  (C) 
Immunoblot analysis of retinal and cerebral homogenate from C57BL/6 wild type mice.   The WiNT 
antibody detects three major bands of approximately 110kD, 60kD and 34kD in both the retina and brain.  
We also detect an additional ~85kD band in the brain, which is not consistently detected in the retina and 
has not been identified.   The WiCT antibody detects three major bands of approximately 110kD, 70kD 
and 60kD in both the retina and brain with an additional ~40kD band only detected in the brain.  See 
Table 1 for GenBank accession numbers and a description of each known whirlin variant.  Artificial 
colorization and merging of the images confirms that only the 110kD, long whirlin isoform is detectable 
by both antibodies and that all short N-terminal and C-terminal isoforms are only detected by their 
respective antibodies. 
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To look for additional C-terminal isoforms, a polyclonal antibody was raised against the 
C-terminus of the long whirlin isoform (amino acids 670-907, GenBank accession, 
NP_082916.1), subsequently referred to as anti-WiCT.  The domain used to generate this 
antibody is illustrated in the antibody map in Fig. 3.2A.  The calculated molecular 
weight of the long whirlin isoform is approximately 98kDa however this isoform 
actually migrates at about 110kDa.  We therefore conclude that the additional isoforms 
recognized by the anti-WiCT antibody (Fig. 2C) correspond to the previously reported 
C-terminal short isoforms with calculated molecular weights ranging between 38.5kDa 
and 58.7kDa. 
 
To further validate that both whirlin antibodies recognized the long whirlin isoform, the 
WiCT antibody was labeled with a horseradish peroxidase tag to eliminate the necessity 
for a secondary antibody in detection.  This permitted sequential probing of the same 
blot with our anti-WiNT and anti-WiCT antibodies without any background signal 
during detection of the second antibody.  Using Adobe Photoshop, we assigned colors to 
and superimposed these images to emphasize that both anti-WiNT and anti-WiCT 
antibodies detect the long whirlin isoform, and that each antibody detects a unique set of 
alternative, short whirlin isoforms (Fig 3.2C). 
 
RPGR
ORF15
 directly interacts with the novel USH2D protein isoform, whirlinNT1 
Having verified the presence of multiple whirlin polypeptides in the retina, the 
RPGR
ORF15
 – whirlin interaction was first validated by MBP pull-down assays, in which 
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a single 75 kDa mRPGR
ORF15
 isoform was incubated with recombinant MBP-
whirlinNT1 fusion protein or MBP alone.  Increasing molar concentrations (0.625mM, 
1.875mM and 5.625mM) of MBP-whirlinNT1 incrementally increased the amount of 
bound RPGR
ORF15 
(Fig. 3.3A).   Interaction between mRPGR
ORF15
 and the equivalent 
molar concentrations of MBP alone could not be detected.   
 
Recombinant domains of whirlin were then used to identify the RPGR
ORF15
 binding 
domain through another series of MBP pull-down assays.   Four MBP-tagged constructs 
were tested:  (i) a construct containing a full PDZ1 domain and truncated PDZ2 domain; 
(ii) the PDZ1 domain only; (iii) the PDZ2 domain only; and (iv) MBP fused to the linker 
region between the two PDZ domains (Fig. 3.3B).  The whirlin PDZ1 and PDZ2 domains 
were identified as independent binding sites for the C-terminus of RPGR
ORF15
 (Fig. 
3.3B).  Importantly, mRPGR
ORF15
 exhibited the highest affinity for whirlin construct 
containing both PDZ domains, suggesting these two domains act cooperatively in whirlin 
binding.  Interaction of neither the MBP-tagged linker domain nor MBP alone could be 
detected.  Thus, we concluded that whirlin and RPGR are interacting proteins and that 
whirlin binds via both PDZ1 and PDZ2 domains to the C-terminal end of RPGR
ORF15
. 
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Figure 3.3.  Confirmation and analysis of RPGR
ORF15
/whirlin interaction.  (A) Extracts of transfected 
HEK293 cells expressing a 75kD RPGR
ORF15
 isoform were incubated with immobilized MBP-tagged 
whirlinNT1 isoform (0.625mM, 1.875mM and 5.625mM) or MBP alone (0.625mM, 1.875mM and 
5.625mM).  Bound RPGR was analyzed by immunoblot with the S1 antibody to identify RPGR isoforms.  
(B) Schematic representation of the various whirlin constructs used and immunoblot analysis of pull-down 
assays used to identify RPGR
ORF15
 binding domain.  From top: MBP protein (negative control); MBP-
whirlinNT1 isoform (positive control); MBP-whirlin PDZ1 domain; MBP-whirlin inter PDZ1/PDZ2 
domain; MBP-whirlin PDZ2 domain.  Increasing molar concentrations (0.625mM, 1.875mM and 
5.625mM) of each fusion protein were immobilized on amylose resin and were incubated with equal 
amounts of HEK293 cells lysate expressing a 75kD RPGR
ORF15
 isoform.  (C) Comparison of RPGR
ORF15
 
interaction with the whirlinNT1 isoform and the long whirlin isoform.  Left: myc-tagged whirlinNT1 and 
whirlin long isoforms from transfected HEK293 cells.  The smaller bands in the whirlin long isoform lane 
are degraded protein detected by the myc antibody.  Right: Immunoblot of binding assay.  Increasing 
amounts of MBP-ORF15 fusion protein were incubated with fixed amounts of either the myc-tagged 
whirlin NT1 or the myc-tagged long whirlin isoform.  The lanes marked by an asterisk indicate the 
negative control in which MBP was substituted at the highest molar concentration of MBP-ORF15 fusion 
protein.  (D) Immunoblot of co-immunoprecipitation to confirm RPGR
ORF15
/whirlin interaction in vivo.  
RPGR was immunoprecipitated from RPGRIP knockout retinal homogenate using anti-S1 antibody.  
Bound protein was analyzed by immunoblot using alkaline phosphatase tagged anti-WiNT antibody.  Left: 
Negative control of immunoprecipitation using pre-inoculated antisera in place of anti-S1 antibody.  Right: 
Immunoprecipitation using anti-S1 antibody. 
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Analysis of RPGR
ORF15
 interaction with the full-length whirlin isoform 
To further characterize the significance of the RPGR
ORF15
 – whirlin interaction, we 
sought to identify whether full-length whirlin was also capable of interacting with 
RPGR
ORF15
.  We incubated the recombinant MBP-tagged RPGR
ORF15
 C-terminal domain 
(amino acids 1241-1343) with equimolar concentrations of myc-tagged whirlinNT1 or 
myc-tagged full-length whirlin and immunoprecipitated with anti-myc antibodies (Fig. 
3.3C).  A recombinant MBP served as a control.  As expected, neither whirlin isoform 
interacted with MBP alone (Fig. 3.3C, asterisks).  Although we detected an interaction 
between myc-whirlinNT1 and MBP-tagged RPGR
ORF15
 C-terminus, we were unable to 
detect an interaction between the full length myc-whirlin and MBP-tagged RPGR
ORF15
 
C-terminus (Fig. 3.3C).  Two possibilities could explain the failure to detect binding 
between RPGR
ORF15
 and full-length whirlin.  First, the protein conformation of the full-
length whirlin isoform may result in structural inhibition of its interaction with 
RPGR
ORF15
.  Second, whirlin is characterized by the presence of three PDZ domains, 
which are protein scaffold domains known to form complexes with a number of other 
proteins.  It is our hypothesis that the multitude of potential interactions between the 
three PDZ domains in full-length whirlin and other proteins in non-neuronal cell lysates 
may interfere with our binding assay.  If this is correct, then it may be possible to detect 
interactions between RPGR
ORF15
 and full-length whirlin in retinal extracts. 
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In vivo confirmation of RPGR
ORF15
/whirlin interaction 
To confirm that RPGR
ORF15
 interacts with the WhirlinNT1 isoform in vivo and to further 
examine whether RPGR
ORF15
 interacts with full-length whirlin, RPGR was 
immunoprecipitated from retinal homogenates using the anti-S1 antibody (50,69).  As a 
negative control, pre-inoculated rabbit serum was used in place of the anti-S1 antibody.  
Initial attempts to immunoprecipitate RPGR from wild type retinas failed to pull down 
detectable levels of either whirlin or RPGR (data not shown).  In wild type retinas, 
RPGR forms a high affinity complex with RPGRIP at the connecting cilium and very 
little soluble RPGR protein is available for immunoprecipitation (50).  RPGR was 
therefore immunoprecipitated from retinal lysates of Rpgrip
-/-
 knockout mice (50,51) and 
the bound whirlin was detected with anti-WiNT antibodies (Fig. 3.3D).  RPGR
ORF15
.  
Co-immunoprecipitated protein was then analyzed by immunoblot analysis using the 
polyclonal, N-terminal whirlin antibody, designated anti-WiNT (Fig. 3.2A).  To 
eliminate direct interaction of the secondary antibody with the anti-S1/RPGR complex, 
we tagged our anti-WiNT antibody with an alkaline phosphatase tag such that it could be 
directly detected by chemiluminescence substrate without subsequent incubation with a 
secondary antibody.  The results from the co-immunoprecipitation assay confirmed our 
hypothesis that RPGR
ORF15
 specifically interacts with the whirlinNT1 isoform in the 
mouse retina.  In addition, we also confirmed that RPGR
ORF15
 exhibits a physiological 
interaction with full-length whirlin and the novel whirlinNT2 isoform (Fig. 3.3D).  
These results suggest that the failure to detect an in vitro interaction between RPGR
ORF15
 
and full-length whirlin is an artifact. 
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RPGR
ORF15
 colocalizes with whirlin in the mouse retina 
RPGR is known to localize in the connecting cilia of both rod and cone photoreceptors 
(37,50,52,54).  Although there have been some conflicting reports regarding localization 
of whirlin (85,91,93,94), our initial hypothesis and subsequent interpretations are based 
on previous reports that whirlin does exist in the connecting cilium, as measured by 
immunogold electron microscopy in both mouse and Xenopus photoreceptors (85), and 
that whirlin has been shown to precipitate with other proteins found predominantly 
within the connecting cilium (85,93,94). 
 
Thus, to add further support for a RPGR
ORF15
 – whirlin interaction in vivo, subcellular 
localization of the proteins were analyzed by co-immunostaining.  Immunohistochemical 
analysis of unfixed retinal cryosections detected whirlin in the vicinity of the connecting 
cilia by both the WiNT and WiCT antibodies.  Significantly, whirlin colocalized with 
RPGR
ORF15
 (Fig. 3.4A-B).  At the light microscopy level, our results correspond well to 
numerous publications that show high-magnification images of whirlin co-localizing 
with markers of the connecting cilium.  We were unable, however, to verify previous 
reports of whirlin in the outer plexiform layer or outer limiting membrane (85). 
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Figure 3.4.  Colocalization of whirlin and RPGR
ORF15
 in the mouse retina by immunohistochemical 
analysis.  (A) Top: Double staining of C57BL/6 wildtype retina with RPGR ORF15 polyclonal antibody 
(red) and WiNT polyclonal antibody (green).  Bottom: Double staining of whirlin knockout retina with 
RPGR ORF15 polyclonal antibody (red) and WiNT polyclonal antibody (green).  (B) Top: Double 
staining of C57BL/6 wildtype retina with RPGR ORF15 polyclonal antibody (red) and WiCT polyclonal 
antibody (green).  Bottom: Double staining of whirlin knockout retina with RPGR ORF15 polyclonal 
antibody (red) and WiCT polyclonal antibody (green).  (A-B) The boxed region on the merged images 
indicates the region shown at right at higher magnification.  The higher magnification merged images 
indicate that both whirlin antibodies partially colocalize with RPGR
ORF15
 in the vicinity of the 
photoreceptor connecting cilia. 
 
 
 
To confirm the specificities of the whirlin antibodies in vivo, we also performed 
immunohistochemistry staining on unfixed retinal cryosections from whirlin knockout 
mice (Fig. 3.4A-B).  As expected, whirlin immunoreactivity was not observed in whirlin 
knockout mice.   Also, localization of RPGR
ORF15
 in the connecting cilia is not 
dependent on whirlin.  Our data indicate that whirlin extensively co-localizes with 
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RPGR
ORF15
 in the photoreceptor connecting cilia and that ciliary localization of 
RPGR
ORF15
 does not depend on whirlin.  
 
Distribution of whirlin in dissociated photoreceptors 
To further examine the co-localization of RPGR
ORF15
 and whirlin at a higher resolution, 
we performed double labeling for RPGR
ORF15
 and whirlin on dissociated photoreceptors.  
Immunofluorescence studies on dissociated photoreceptors are commonly done to 
provide better spatial resolution of certain proteins (54,69,95,96).  This approach often 
provides better staining due to differences in fixation methods and availability of 
epitopes.   
 
Comparison of the immunofluorescence images double-labeled with our anti-WiNT and 
anti-RPGR ORF15 antibodies confirmed co-localization of the interacting proteins 
within the connecting cilium (Fig. 3.5A; arrowhead) In addition to localization in the 
connecting cilia, our WiNT antibody also exhibited punctate staining along the rootlet, 
as is shown in the co-localization with anti-rootletin antibody in Fig. 3.5B.  We also co-
immunolabeled dissociated photoreceptors using our anti-WiCT and anti-RPGR
ORF15
 
antibodies, which again confirmed co-localization of RPGR
ORF15
 and whirlin in the 
photoreceptor connecting cilia (Fig. 3.5C).  Our anti-WiCT labeling was not restricted to 
the connecting cilia and exhibited a punctate staining pattern in the photoreceptor outer 
segment that colocalized with rhodopsin (Fig. 3.5D).  We were unable to detect whirlin 
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localization in the pericilliary region with either antibody due to the physical disruption 
of the cell used to obtain dissociated photoreceptors fragments.   
 
 
Figure 3.5.  Subcellular localization of whirlin isoforms in dissociated retinal photoreceptors.  (A) Double 
staining for whirlin N-terminal isoforms and RPGR
ORF15
.  (B) Double staining for whirlin N-terminal 
isoforms and Rootletin.  (C) Double staining for whirlin C-terminal isoforms and RPGR
ORF15
.  (D) Double 
staining for whirlin C-terminal isoforms and rhodopsin.  Arrowheads indicate areas of colocalization 
within the connecting cilium. 
 
 
 
Thus, immunostaining of dissociated photoreceptors not only confirms the co-
localization of RPGR
ORF15 
and whirlin in the connecting cilia, but also demonstrates that 
the different whirlin isoforms show distinct localization patterns within photoreceptors 
and therefore may have distinct functions within the subcellular compartments of 
photoreceptors.  
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Discussion 
Mutations in RPGR are one of the most frequent causes of inherited retinal degeneration.  
Based on mutational analysis and previous studies of RPGR null and transgenic mice, 
the photoreceptor specific RPGR
ORF15
 isoforms are essential to photoreceptor 
maintenance and survival.  In this study, we identified the Usher protein whirlin as a 
novel interactor with RPGR, and by transcriptional and protein analysis of whirlin 
expression identified two novel N-terminal short whirlin isoforms (Fig. 6).  Our data 
also indicate that these short N-terminal variants and the previously reported short C-
terminal variants have different subcellular localizations within photoreceptors and thus 
may retain discrete functions.  The whirlin – RPGRORF15 interaction identified in this 
study provides the first evidence linking RPGR
ORF15
 to the Usher protein network, 
thereby indirectly connecting RPGR
ORF15
 to a number of other proteins also known to 
cause RP.  The analogous retinal phenotypes associated with mutations in these loci 
indicate a physiologically significant interaction that may provide further evidence to the 
function of these proteins in photoreceptors. 
 
WHRN/DFNB31 was first identified as a novel locus responsible for an autosomal 
recessive form of non-syndromic, congenital deafness, identified as DFNB31 (87).  
Recently, mutations in whirlin have been found to underlie Usher Syndrome, type IID 
(USH2D), an autosomal recessive condition that manifests as both congenital hearing 
loss and visual impairment resulting from retinitis pigmentosa (88).  Ebermann et al. 
(2007) proposed that the genotype-phenotype correlation (non-syndromic deafness vs. 
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Mutations in RPGR are one of the most frequent causes of inherited retinal degeneration.  
Based on mutational analysis and previous studies of RPGR null and transgenic mice, 
the photoreceptor specific RPGR
ORF15
 isoforms are essential to photoreceptor 
maintenance and survival.  In this study, we identified the Usher protein whirlin as a 
novel interactor with RPGR, and by transcriptional and protein analysis of whirlin 
expression identified two novel N-terminal short whirlin isoforms (Fig. 6).  Our data 
also indicate that these short N-terminal variants and the previously reported short C-
terminal variants have different subcellular localizations within photoreceptors and thus 
may retain discrete functions.  The whirlin – RPGRORF15 interaction identified in this 
study provides the first evidence linking RPGR
ORF15
 to the Usher protein network, 
thereby indirectly connecting RPGR
ORF15
 to a number of other proteins also known to 
cause RP.  The analogous retinal phenotypes associated with mutations in these loci 
indicate a physiologically significant interaction that may provide further evidence to the 
function of these proteins in photoreceptors. 
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USH2D) may be dependent on the location of a given mutation within the whirlin gene 
locus.  While the first disease-causing mutations identified in humans truncated the 
protein close to its C-terminus and caused DFNB31, they reported compound 
heterozygosity affecting the integrity of the 5‟ end of the WHRN gene as the causative 
loci in a patient with USH2D.  Their theory was further supported in a recent study (91) 
comparing a whirlin knockout mouse to the whirler mouse.  The whirler mouse has a 
large deletion in the 3‟ end of the whirlin gene (Fig. 3.6B) and is phenotypically similar 
to DFNB31 patients (90); however, targeted deletion of the whirlin gene, which affects 
both the long and short, C-terminal whirlin variants,  results in both retinal and inner ear 
defects that resemble the human USH2D phenotype (91).  Our study, however, provides 
the first physiological evidence to suggest such phenotypic differences reflect the 
variable protein interactions, subcellular localization, and likely independent function of 
the short N-terminal and C-terminal whirlin isoforms.  
 
First and foremost, our key finding is the identification of a novel interaction between 
whirlin and RPGR
ORF15
.  Since RPGR
ORF15
 interacts with the PDZ1 and PDZ2 domains 
of whirlin, our data imply that these N-terminal domains retain an important functional 
role in photoreceptors.  Furthermore, identification of two short, N-terminal whirlin 
isoforms suggests that not only do the N-terminal PDZ domains boast specific and 
distinct interactions, but that differential expression of the whirlin gene produces both N-
terminal and C-terminal variants.  In contrast to the previously reported C-terminal 
variants, which encode the PDZ3 domain and proline-rich region, the first of these novel 
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N-terminal isoforms encodes only the PDZ1 domain and undergoes internal truncation 
within the PDZ2 domain, while the second encodes both the PDZ1 and PDZ2 domains 
(Fig. 6).  This indicates that whirlin undergoes alternative splicing to produce variable 
isoforms, each possessing a unique combination of domains and potentially independent 
function. 
 
In summary, the data in this study clearly demonstrate that direct protein-protein 
interaction between RPGR
ORF15
 and whirlin connects RPGR
ORF15
 to the extensive Usher 
protein network.  This study also shows the presence of two novel, N-terminal short 
whirlin variants at the mRNA and protein level and further validates the significance of 
the integrity of the 5‟ end of the whirlin/DFNB31 gene in photoreceptor function and 
survival.  Future investigations into the relationship of RPGR
ORF15
 and the Usher protein 
network may provide further insight into the function of the ORF15 isoforms as well as 
the physiology of this growing „interactome‟. 
 
Mutations in RPGR are one of the most frequent causes of inherited retinal degeneration.  
Based on mutational analysis and previous studies of RPGR null and transgenic mice, 
the photoreceptor specific RPGR
ORF15
 isoforms are essential to photoreceptor 
maintenance and survival.  In this study, we identified the Usher protein whirlin as a 
novel interactor with RPGR, and by transcriptional and protein analysis of whirlin 
expression identified two novel N-terminal short whirlin isoforms (Fig. 6).  Our data 
also indicate that these short N-terminal variants and the previously reported short C-
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terminal variants have different subcellular localizations within photoreceptors and thus 
may retain discrete functions.  The whirlin – RPGRORF15 interaction identified in this 
study provides the first evidence linking RPGR
ORF15
 to the Usher protein network, 
thereby indirectly connecting RPGR
ORF15
 to a number of other proteins also known to 
cause RP.  The analogous retinal phenotypes associated with mutations in these loci 
indicate a physiologically significant interaction that may provide further evidence to the 
function of these proteins in photoreceptors. 
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CHAPTER IV 
 
CONCLUSIONS 
Summary 
An important finding of this work is that Rpgr expression exhibits dynamic temporal 
regulation during retinal development and that Rpgr variants exhibit variability toward 
localization in the connecting cilia of mature photoreceptors.  Previous analyses of Rpgr-
null mice report that mammalian photoreceptors undergo normal physiological 
development despite an absence of Rpgr (54), suggesting that Rpgr is not required for 
development.  However, the temporal regulation of Rpgr taken together with the robust 
expression of the Rpgr
ex1-19
 variant during retinal development is nonetheless suggestive 
of a functional role for Rpgr in cellular development.  In addition, we report that 
emergence of the Rpgr
ORF15
 variants follows a reciprocal expression pattern, coinciding 
with photoreceptor maturation.  This finding upholds the long held notion that Rpgr
ORF15
 
plays an essential role in sustaining the normal physiology of mature photoreceptors 
(54).  While it has been speculated that Rpgr
ORF15
 is the only functionally significant 
variant in photoreceptors (60), the dynamics of Rpgr expression in emerging 
photoreceptors described herein suggests that both the Rpgr
ORF15
 and Rpgr
ex1-19
 variants 
retain some independent, isoform specific functions. 
 
In this study, we also use transgenic mouse models to examine the phenotypic effects of 
gross overexpression of the Rpgr
ex1-19
 and Rpgr
ORF15
 variants in photoreceptors and to 
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evaluate whether the Rpgr
ex1-19
 variant alone is capable of restoring function to 
photoreceptors lacking endogenous Rpgr.  Although transgenic expression of both 
variants exhibits normal ciliary localization, misexpression of the Rpgr
ex1-19
 variant 
results in abnormal accumulation of Rpgr in photoreceptor outer segments.  Interaction 
of the Rpgr
ex1-19 
variant with the membranous outer segments results in unusual 
histopathological changes in outer segment morphology.  The severity of the disease 
course is substantially more acute than that described in previous reports of Rpgr null 
mutant mice (54).  Interestingly, photoreceptors tolerate overexpression of the Rpgr
ORF15
 
variant without evidence of degeneration.  Since similar misexpression of the Rpgr
ORF15
 
variant results in neither atypical accumulation of protein in the outer segment nor a 
degenerative retinal phenotype, we conclude that our report describes an Rpgr
ex1-19
 
specific phenomenon rather than a non-specific consequence associated with the intense 
level of overexpression.   
 
Given that the Rpgr
ex1-19
 variant differs from the Rpgr
ORF15
 variant by the presence of a 
C-terminal isoprenylation motif (25,37,46,79), we hypothesize that the mislocalized 
accumulation of excess Rpgr
ex1-19
 protein observed in photoreceptor outer segments by 
immunofluorescence is likely related to the membranous nature of the outer segment 
structure and innate properties of the isoprenylation signal.  In general, isoprenylation 
motifs signal the addition of prenyl groups at carboxy-terminal cysteine residues, which 
are known to anchor proteins to cell membranes (77,78).  By electron microscopy, it is 
clear that accumulation of Rpgr
ex1-19
 protein in the photoreceptor outer segments both 
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functionally and morphologically disrupts the organized structure of the outer segments‟ 
membranous disks.   
 
With diminished expression of endogenous Rpgr
ex1-19
 in mature photoreceptors and the 
affinity of Rpgr
ex1-19
 to tightly bind Rpgrip in the connecting cilia(44,45,50), the 
presence of Rpgrip is likely sufficient to limit localization of endogenous Rpgr to the 
connecting cilia.  This would suggest that if the concentration of Rpgr
ex1-19
 exceeds the 
binding capacity of Rpgrip or if binding is otherwise interrupted, default may begin to 
mislocalize and accumulate in the photoreceptor outer segments, as is observed in our 
transgenic mouse model.   
 
Although endogenous Rpgr
ex1-19
 expression in adult photoreceptors is minimal, further 
investigation of this artificial system may nonetheless provide evidence of native 
Rpgr
ex1-19
 function in developing and/or mature photoreceptors, and may reveal the 
importance of proper down-regulation of the Rpgr
ex1-19
 variant in mature cells.  For 
example, isoprenylation of Rpgr may be required for some form of ciliary trafficking 
during very early stages of photoreceptor development before the appearance of the 
outer segments.  Thus, the Rpgr
ex1-19
 variants may possess different functions during 
early development when expression is robust, as compared to the function of Rpgr
ORF15
 
following ciliogenesis and outer segment maturation.   
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The reciprocal emergence of the Rpgr
ORF15
 variant, described herein, which coincides 
with photoreceptor maturation, further supports the long held hypothesis, based on 
mutational analysis and previous studies of Rpgr null and transgenic mice, that the 
photoreceptor specific Rpgr
ORF15
 isoforms are essential to the maintenance and survival 
of mature photoreceptors (60).  Such an independent function would suggest that the 
domain encoded by exon ORF14/15, which differentiates between the Rpgr
ex1-19
 and 
Rpgr
ORF15
 variants, should have unique interacting partners in the retina.  Thus, we used 
a yeast two-hybrid screen to further elucidate the function of the ORF15 variants by 
identifying potential interacting partners of the C-terminus of Rpgr
ORF15
. 
 
We identified the Usher protein whirlin, a putative PDZ scaffold protein expressed in 
cochlear hair cells and retinal photoreceptors, as a novel interactor of Rpgr
ORF15
.  
Mutations in the whirlin (WHRN/DFNB31) locus are responsible for DFNB31, an 
autosomal recessive form of non-syndromic, congenital deafness (87), and Usher 
Syndrome, type IID (USH2D), an autosomal recessive condition characterized by both 
congenital hearing loss and visual impairment resulting from retinitis pigmentosa (88).  
The physiologically significant whirlin-Rpgr
ORF15
 interaction described provides a novel 
mechanism for the RP phenotype associated with USH2D. 
 
Since whirlin is a member of the extensive Usher protein network, a dynamic complex 
which includes motor proteins, scaffold proteins, cell adhesion molecules and 
transmembrane receptors critical for development and maintenance of these 
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sensorineural cells (80,82-86,97), the direct protein-protein interaction between 
Rpgr
ORF15
 and whirlin described provides the first evidence connecting Rpgr to the 
extensive Usher protein network, thereby indirectly connecting Rpgr
ORF15
 to a  number 
of other proteins also known to cause RP.  The analogous retinal phenotypes associated 
with mutations in these loci indicate a physiologically significant interaction that may 
provide further evidence to the function of these proteins in photoreceptors.   
 
In addition to identifying a direct association between whirlin and Rpgr
ORF15
, we also 
identified two novel N-terminal short whirlin isoforms by transcriptional and protein 
analysis of whirlin expression.  This indicates that differential expression of the whirlin 
gene produces N-terminal variants in addition to the previously reported C-terminal 
variants and that alternative splicing of the whirlin transcript results in expression of 
variable isoforms possessing a unique combination of domains.  Unlike the C-terminal 
variants, which encode only the proline-rich region and PDZ3 domain, the first of these 
novel N-terminal isoforms encodes the PDZ1 domain and undergoes internal truncation 
within the PDZ2 domain, while the second encodes both the PDZ1 and PDZ2 domains.  
Our data also indicate that these short N-terminal variants and C-terminal variants have 
distinct subcellular localization patterns within photoreceptors.  
 
In conclusion, this study clearly demonstrates that direct protein-protein interaction 
between Rpgr
ORF15
 and whirlin connects Rpgr to the extensive Usher protein network 
and also shows the presence of two novel, N-terminal short whirlin variants at the 
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mRNA and protein level in photoreceptors.  Together, these data validate the 
significance of the integrity of the 5‟ end of the whirlin/DFNB31 gene in photoreceptor 
function and survival.   
  
Recommendations 
We have previously shown that expression of a single, internally truncated Rpgr
ORF15
 
variant substantially rescues the Rpgr null phenotype (60).  However, since there is a 
void in knowledge regarding protein expression in RPGR patients, these more recent 
findings should also be taken into consideration when exploring treatment options using 
gene therapy.  Although a majority of RPGR mutations are in the ORF15 exon and only 
directly affect the RPGR
ORF15 
variants, there is some possibility of indirect effects on 
RPGR
ex1-19
 expression.  Given that all RPGR variants are under the control of a single 
promoter, it is possible that RPGR
ex1-19 
expression may be affected by endogenous 
efforts to compensate for the loss of functional Rpgr
ORF15
.  If further studies support this 
theory, then introduction of the RPGR
ORF15 
variant by gene therapy may potentially 
affect endogenous RPGR
ex1-19 
expression, in which case, up-regulation of RPGR
ex1-19 
expression may prove more detrimental to photoreceptor integrity and incite disease 
progression than the lack of functional RPGR
ORF15
. 
 
Further investigation of protein expression in RPGR patients would provide valuable 
information and would be beneficial in alleviating this concern.  However, given the 
difficulty of obtaining retinal tissue samples from RPGR patients prior to disease 
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progression, well designed studies utilizing cell culture and transgenic mouse models 
may have to substitute.  Since expression of the Rpgr
ORF15
 transgene in the mROIF 
transgenic line described in this study closely mimics the expression pattern of 
endogenous Rpgr
ORF15
, we have generated another mouse model expressing the same 
construct with a single base-pair deletion in the purine-rich region of the ORF14/15 
exon.  This mutation is similar to the type of mutations often described in RPGR 
patients.  Transcriptional and protein analysis of this line is expected to provide valuable 
clues regarding the effects of ORF14/15 mutations on the complex internal splicing of 
the RPGR
ORF15
 variants.  We have also found that transient transfection of HEK293 cells 
with our wild-type and mutant RpgrORF15 transgenic constructs results in expression 
patterns similar to that seen in retinal homogenate from the transgenic mice.  Utilization 
of this in vitro system would be a more efficient and cost-effective method for 
examining the affects of various types of mutations.  Because of the unpredictability of 
internal splicing in the ORF14/15 exon, transitions, transversions, insertions and 
deletions in the purine-rich region may have unexpected impacts on the protein 
sequence.  In addition to producing an Rpgr
ORF15
 specific polyclonal antibody to 
recognize the C-terminus of the ORF15 domain, we also recommended designing 
expression constructs with three C-terminal frame-shift tags so that the affects of 
splicing at the protein level may be assessed by immunoblot utilizing tag-specific 
antibodies. 
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Although these experiments would provide valuable insight relating to endogenous 
Rpgr
ORF15
 expression and the effects of ORF15 mutations on protein expression, these 
studies would not be sufficient in alleviating the previously mentioned concerns 
regarding the single Rpgr promoter and the effects of Rpgr
ORF15
 mutations on Rpgr
ex1-19
 
expression.  Thus, we recommend generating a mutant Rpgr
ORF15
 knock-in mouse model 
for additional studies.  This would provide an excellent model for future gene therapy 
studies. 
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